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Abstract

SPAG16 IS A BIFUNCTIONAL GENE REGULATING MALE FERTILITY
By Davíd Roberto de Vela Nagarkatti-Gude, A.B.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2012.
Major Director: Jerome F. Strauss III, M.D., Ph.D.
Dean, School of Medicine
Professor of Obstetrics and Gynecology, Biochemistry and Molecular Biology
SPAG16 is the murine orthologue of Chlamydomonas reinhardtii PF20, a protein known
to be essential to the structure and function of the “9 + 2” axoneme. The “9 + 2” axoneme
provides the cytoskeletal core of all eukaryotic motile cilia and flagella. In
Chlamydomonas, the Pf20 gene encodes a single protein present in the central pair of
the axoneme. Loss of Pf20 prevents central pair assembly and results in flagellar
paralysis. The murine Spag16 gene encodes two proteins. While 71 kDa SPAG16L is
found in all murine cells with motile cilia or flagella, 35 kDa SPAG16S transcript and
protein are detected only in male germ cells, suggesting a unique role distinct from
general axoneme formation. Transgenic mouse studies published previously by our lab
have shown that abrogation of both SPAG16 isoforms causes arrest of spermatogenesis,
and the mutant allele is not transmitted to offspring by chimeric males. Mice homozygous
for a knock-out of SPAG16L alone are infertile, but show no abnormalities in

spermatogenesis. The defects seen in chimeric Spag16 mutant mice, unaccounted for by
loss of SPAG16L, indicate a possible role for SPAG16S in the specialized process of
male germ cell development. Our results demonstrate that SPAG16S is predominantly
found in specific regions within the nucleus of round spermatids. These nuclear subdomains also contain SC35, a known marker of nuclear speckles enriched in pre-mRNA
splicing factors. Putative interaction partners of SPAG16S are also shown to play critical
roles in the peri-nuclear region during the round spermatid transition to the condensation
and elongation stage of spermiogenesis, the final specialization point in sperm
development. The distinct localization of SPAG16S at this critical juncture, its interaction
with discretely localized proteins at a critical temporal junction in spermatogenesis, and
its ability to modulate SPAG16L expression, suggest that SPAG16S plays an important
role in the gene expression machinery of male germ cells, and represents an
evolutionary distinction in axoneme gene function.

Chapter 1: General Introduction

Early Discoveries
In the mid-17th century, a one-time haberdasher and civic official in Delft began to perfect
a proprietary approach to glass lens manufacture, enabling him to produce smaller, more
perfect spheres than any previously available. At a time when most microscopic
observations were still severely limited in magnification, Leeuwenhoek produced single
lens, simple microscopes capable of up to 300X amplification (Huxley 2007).
Leeuwenhoek’s carefully honed spheres became one of the most important technological
breakthroughs of modern science, granting powerful new opportunities to explore the
sub-microscopic world. Over five decades of active investigation, Leeuwenhoek became
the first scientist to describe muscle fibers, blood flow, and structures of bacteria, earning
the title “Father of Microbiology” for his groundbreaking reports (Dobell and
Leeuwenhoek 1932).

While he is most famous for his descriptions of bacterial structure, Leeuwenhoek
produced a diverse body of work. After years of wrestling with one of the most shocking
discoveries afforded by his inquiries, in 1677 he penned a letter to the Royal Society of
London, excitedly describing a new finding:
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“… and I have seen so great a number of living animalcules… in it, that sometimes more
than a thousand were moving about in an amount of material the size of a grain of
sand…” (letter to W. Brouncker, President of the Royal Society of London, Nov 1677, in
(Leeuwenhoek and Rijnberk 1939))

Leeuwenhoek was describing, for the first time in history, the microscopic contents of
human semen. His observations challenged Church doctrine that organisms were
fundamentally divided into two groups: large, procreating, creatures, and small,
spontaneously generating life forms (letter to Anthonio Magliabechi, Oct 1699, in
(Leeuwenhoek and Rijnberk 1939)). Though Leeuwenhoek himself was a devout
Calvinist, and indeed was profoundly troubled by the implications of his findings (Huxley
2007), his report posed a fundamental challenge to contemporary European beliefs on
the nature of the human soul - procreation could no longer be assumed to result from a
purely spiritual union. Leeuwenhoek’s work suggested that human life might begin from
just one of millions of tiny, single cells, each with the potential to give rise to a new being.

Strategies in Contraception
In bi-gendered species, males are defined as the gender producing numerous small,
motile gametes, termed spermatozoa (Bishop and Walton “Spermatogenesis and the
structure of mammalian spermatozoa” in (Marshall, Lamming et al. 1984))(Birkhead,
Pellatt et al. 1988). Evolutionary biologists have interpreted this strategy as a
consequence of the challenge of genetic competition; for the non-gestating partner,
producing more gametes increases the likelihood of reproductive success (Kilgallon and
4

Simmons 2005; Parker and Ball 2005). It has even been proposed that quality and
quantity of male gamete output varies dynamically with perceived reproductive
competition, a complex psychophysiological response to the challenge of ensuring
genetic continuity (Friedmann 1981; Law 1986).

As a result of this prodigious and continuous production of viable sperm, male
contraception requires fundamentally different approaches than those collectively
referred to as “the Pill,” the array of hormone regimens that suppress female ovulation.
The human female menstrual cycle is a well characterized and highly regulated series of
physiological changes focused on the production, typically, of a single ovum. Over the
course of an average 28-29 days cycle (Clifton, Kaneda et al. 2008), the endocrine
system primes the uterus to become a hospitable environment for implantation and
gestation. If fertilization does not occur, the uterine lining is secreted and a new round of
hormonal surges triggers the cycle to begin again.

Female oral contraceptives, which employ progesterone alone or in combination with
estrogen as well, are employed by 18% of contraceptive users worldwide (National
Prescribing Service 2007). When taken perfectly as prescribed (usually a daily
administration in the case of oral dosing), pregnancy rates are around 0.3% (Fu, Darroch
et al. 1999; Hatcher 2007; Halpern, Lopez et al. 2011). However, typical real world
adherence results in a failure rate of approximately 8% during the first year of use
(Hassan and Killick 2004).
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Contraceptive failure is not the only drawback to these medications – reported side
effects include impaired recovery of fertility (Shufelt and Bairey Merz 2009; BlancoMolina and Monreal 2010), deep venous thrombosis (La Vecchia and Bosetti 2009;
Cibula, Gompel et al. 2010), and certain types of neoplasm (Keith, Keith et al. 1975;
Heinemann, Saad et al. 2005; Heinemann, Saad et al. 2005). While these medications
are highly effective, and the vast majority of studies have demonstrated the health risks
of hormonal contraceptives to be quite limited, both the reality of their side effects and
patient concerns arising from perceived risk suggest that alternative approaches are
highly desirable.

Male Hormone Contraception
Reports have indicated that the majority of men would be willing to take a perfected oral
contraceptive pill (Oudshoorn 2003), and researchers have been optimistic about
producing one for decades. Over 50 years have passed since leaders in China and India
labeled male contraceptives as the critical missing element in population control
programs (Zatuchni, Goldsmith et al. 1986). Early research sought a quick-acting agent
to disrupt sperm production by direct inhibition of hormone function, and later by targeting
various steps in the endocrine control pathway (reviewed in (Heckel, Rosso et al. 1951)),
based on the early observation that testosterone itself was antispermatogenic in rats
(Steinberger and Smith 1977; Swerdloff, Peterson et al. 1978). Many of the first studies
focused on estrogens, which have long been used in treatment of prostate cancer and
are known to disrupt spermatogenesis. However, the long-term feminizing effects of
estrogen treatment are unacceptable, and require counter-administration of testosterone
6

(Oudshoorn 2003), which still does not fully overcome reduced libido, acne, testicular
shrinkage, and breast growth (Farrell, Joshua et al. 1975). In addition to creating a
complex clinical protocol for administration, androgens also carry their own risks,
including hepatic damage (Muldoon, Mahesh et al. 1982) and neoplasm (Zatuchni,
Goldsmith et al. 1986). Moreover, onset may take up to several years (NJ Alexander
“Sites for Disruption of Male Fertility” in (Prasad and Diczfalusy 1983; Qian and Wang
1984)).

Gossypol
Clearly, an approach is necessary that targets male fertility more specifically, rather than
mimicking the strategy of female oral contraceptives. In the 1980s, significant research
efforts focused on gossypol, a naturally-occurring chemical derived from cotton seeds
(Shepu, Shudong et al. 1980; Wen 1980). A polpyhenol, gossypol’s direct cellular target
remains controversial. Despite limited mechanistic data, gossypol was reported to be
safe and effective following a trial in 4,000 Chinese men, who exhibited decrease in
motile sperm and eventual oligozoospermia and azoospermia (Coutinho, Athayde et al.
2000). Subsequent studies have in fact demonstrated that gossypol is well tolerated
during continuous dosing, and potential toxicities such as hypokalemia can be
significantly diminished by routine clinical check-up (Liu and Lyle 1987; Liu, Lyle et al.
1987; Liu, Lyle et al. 1987). However, gossypol appears to be too potent; infertility is
markedly prolonged in up to 50% of users, and, critically, is irreversible in 10-20% of
users after administration is stopped (Ansbacher 1971; Shulman, Zappi et al. 1972).
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Vasectomy
Vasectomy, a surgical severing and tying off of the vas deferens, is highly effective in
preventing male fertility, and has been safely practiced for decades. The procedure is
widely available, is performed on an out-patient basis, and requires less than half an
hour. For men who desire a permanent approach to contraception, vasectomy offers a
safe and convenient way to achieve this goal without major lifestyle changes.

However, numerous studies have raised concerns regarding unforeseen side effects of
vasectomy. It is well established that circulating levels of anti-sperm antibodies are
increased following vasectomy (Nagarkatti and Rao 1976; McDonald and Halliday 1992),
and cell-mediated immune responses to spermatozoa have been observed as well
(Witkin, Zelikovsky et al. 1982). Additionally, immune complexes in general are elevated
in vasectomized men (Alexander and Clarkson 1978; Clarkson and Alexander 1980).
Several reports have also proposed a link between vasectomy and cardiovascular
disease (Ross, Paganini-Hill et al. 1983; Sidney 1987; Honda, Bernstein et al. 1988;
Newell, Fueger et al. 1989). Early studies also suggested an increased risk of certain
genitourinary concerns, including prostate (Goldacre, Clarke et al. 1978; Strader, Weiss
et al. 1988; Thornhill, Conroy et al. 1988; Cale, Farouk et al. 1990) and testicular cancers
(Schwingl and Guess 2000; Kohler, Fazili et al. 2009).

Follow-up studies and meta-analyses have repeatedly shown these links between
vasectomy and pathologies to be unsubstantiated, and have suggested the surgery is
safe for the vast majority of potential patients (reviewed in (Lee, Li et al. 2008)).
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Nevertheless, there are substantial costs to vasectomy. The procedure is irreversible in
just under half of cases (Robles, Martinez et al. 1987; Santiso 1988; Sharma and Sharma
1996), and acceptance varies significantly amongst different cultures (Inhorn 2009). Even
in groups where vasectomy is regularly employed as a contraception technique, it is not
uncommon for men to feel somewhat diminished by knowledge of their own sterility,
stating e.g. “It’s a bit unmanly in a way” (Roberts 2000; Rowlands 2002; Pollack 2003).
Both US and UK guidelines state that the surgery should be viewed as a permanent
sterilization, and should be performed only on patients who definitely do not want to
father children in the future (Fenster and McLoughlin 1981; Belker, Thomas et al. 1991;
Potts, Pasqualotto et al. 1999; Sandlow, Westefeld et al. 2001). Despite careful preoperational screening, 3-6% of vasectomy patients eventually seek reversal (Fenster and
McLoughlin 1981; Belker, Thomas et al. 1991), and the more time that passes after
vasectomy, the lower the chances are that fertility will be successfully restored
(Birenbaum-Carmeli, Carmeli et al. 1995).

Male Infertility
Unlike the nascent state of male birth control, medical technology is somewhat more
advanced in the treatment of impaired male fertility. Nevertheless, the basic framework of
knowledge regarding andrology and male infertility remains limited (Cates, Farley et al.
1985; World Health Organization 1987; Outlook 2002; Potter and Hanin 2005). Estimates
shown that approximately 1 in 7 couples will experience difficulty conceiving (Bhasin
2007), and that in instances of sub-fertility, male factor infertility is involved in roughly
50% of cases (Whorton, Krauss et al. 1977; Wyrobek, Gordon et al. 1983; Schrader,
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Turner et al. 1991). Moreover, infertility rates have been widely reported to be increasing,
with links drawn to environmental and occupational toxins (Auger, Kunstmann et al.
1995; Irvine, Cawood et al. 1996; Selevan, Borkovec et al. 2000; Jorgensen, Carlsen et
al. 2002). Most studies have focused on industrialized nations, citing reduced sperm
counts and increased rates of abnormal sperm morphology in young men (Olsen, Bodner
et al. 1995; Fisch, Goluboff et al. 1996), though these findings have been somewhat
controversial (Irvine, Cawood et al. 1996). Reports not only point out trends of reduced
male fertility, but tend towards alarmist tones, calling “urgently” for more data (Katz 1994;
Birenbaum-Carmeli, Carmeli et al. 1995; Inhorn 2004). Social scientists have reported
widely that male infertility seems more strongly stigmatized (Carmeli et al. in (Inhorn
2009)) citing anecdotes of severe anxiety at the prospect of being completely infertile:

“The men feel so bad if they don’t have sperm. They will be so happy to know that they
have sperm, even if none of them are motile. When I tell them they have sperm, they are
crying. Sometimes they hug me. They speak about [sperm] donation, and he feels
miserable. I spoke to a man who was told he was azoospermic. I told him to bring me a
slide of his testis. I put it on my electro-microscope and showed him where the sperm
were. I told him, “You are not azoospermic.” He was holding me and kissing me. (from H
Goldberg in (Inhorn and Balen 2002; Teman 2003))

In fact, current fertility treatments have made possible the successful use of lower quality
and even immotile sperm. While research has focused more strongly on female infertility
(reviewed in (Rodriguez-Martinez 2006)) advances in fertility drugs and in the techniques
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of in vitro fertilization (IVF) have reduced the need for quantity and quality of sperm that
would traditionally be required for unperturbed fertility (Maggiulli, Neri et al.; Setti,
Figueira et al. 2010). Micromanipulation and advanced screening of male gametes has
allowed a targeted, “modified” approach to intracytoplasmic sperm injection (IMSI, a
modified approach to ICSI) that has raised successful pregnancy rates in couples with
clinically-diagnosed male infertility on par with those of couples requiring simple in vitro
semination (Fortunato and Tosti 2011). While these advances have been welcomed by
hopeful couples and by practitioners, concerns have been raised that the practice of in
vitro fertilization produces more birth defects and subsequent pathologies than are
observed with traditional procreation, perhaps owing to reduced quality of gametes used
and imperfect conditions of the in vitro environment (Lokman and Moore; Nagano 2011).
Researchers have continued to focus on methods to induce the production of improved
sperm, but these techniques remain elusive (Austin and Short 1972).

Spermatogenesis
The most promising approaches to both targeted male contraception and enhanced male
fertility lie in a deeper understanding of spermatogenesis, the highly specialized process
that generates male gametes capable of: 1) directed motility; 2) recognition of the female
ovum; 3) binding to the ovum; 4) penetration of and fusion with the ovum, i.e.
capacitation (Clermont and Trott 1969). This process takes a total of 35 days in mice,
and 74 days in humans (Brehm and Steger 2005). Male gametes are produced from a
population of spermatogonial stem cells, and derive from a maturation process that can
be divided into three distinct stages (Hess and Renato de Franca 2008).
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In the first stage of spermatogenesis, spermatogonial stem cells divide by mitosis, with
one daughter cell continuing the stem cell population while the other differentiates and
matures. In the second stage of spermatogenesis, meiotic division of a primary
spermatocyte results in the production of four round spermatids. In the final differentiation
step, spermiogenesis, round spermatids produced by meiosis mature into functional
spermatozoa. In this final step, differentiating sperm develop specialized structures, such
as the flagellum, acrosome, and condensed nucleus, critical to their unique reproductive
function.

Seminiferous Tubules
The majority of the process of spermatogenesis takes place within the seminiferous
tubules of the testis (Skinner and Griswold 2005). Seminiferous tubules are arranged as
rings, with undifferentiated cells at the periphery maturing as they move towards the
lumen. This architecture is established by the seminiferous epithelium, consisting of germ
cells interspersed with Sertoli cells, the only somatic cells present within the tubules and
a critical participant in sperm maturation (R Hess and LR Franca in (Hess and Renato de
Franca 2008))(Leblond and Clermont 1952).

While the seminiferous epithelium represents a mixture of Sertoli cells and various germ
cell types, investigators have divided the epithelium into several stages based on the
mixture of cells present in a given tubular cross section, defining twelve stages (I-XII) in
rodents (Clermont 1963) and six stages (I-VI) in men (Russell 1990). This convention
12

provides a common framework and vocabulary for researchers to address pathologies
that perturb the normal distribution within the cycle of cells undergoing spermatogenetic
differentiation. Spermatogenesis has been studied most extensively in the mouse, where
staging is commonly grouped into ‘Early’ stages I-V, ‘Middle’ stages VI-VIII, and ‘Late’
stages IX-XII (Grudzinskas and Yovich 1995).

Epididymis
As haploid round spermatids elongate and condense during spermiogenesis, the
maturing spermatozoa are released into the seminiferous tubule lumen. Final sperm
maturation takes place as spermatozoa move from the lumen into the epididymis, where
they are stored until ejaculation (reviewed by HDM Moore in (Hess and Chen 1992)).
Storage time varies among animals, and is known to be affected by scrotal temperature,
which also modulates the duration of spermatogenesis (Bedford 1965; Bedford 1967;
Cooper 1998; Toshimori 1998). As spermatozoa move into the epididymis, they are still
not functionally mature – they lack forward motility and the ability to recognize the oocyte
zona pellucida (Sullivan, Frenette et al. 2007). These functions are acquired within the
epididymis under the direction of a group of molecules collectives designated
“epididymosomes” (Toshimori, Kuwajima et al. 1999). Impairment of this process limits
sperm motility and significantly reduces fertility (Connell 1976).

Leydig cells
Both Sertoli cells and spermatogonia are supported by paracrine signaling from Leydig
cells residing in the interstitial space outside the seminiferous tubules. While other cells,
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such as fibroblasts, macrophages, and mast cells, are also present in the interstitium
(Schulze 1984), Leydig cells are the primary resident cell type with a direct and
necessary effect on spermatogenesis. The primary responsibility of Leydig cells is to
produce testosterone in response to luteinizing hormone (LH) (Andersson, Jorgensen et
al. 2004). The testosterone released by Leydig cells diffuses to Sertoli cells and
spermatogonia within the seminiferous tubule, effecting critical paracrine stimulation of
spermatogenesis. As 12-15% of men with diminished spermatogenesis exhibit reduced
testosterone levels, it can be inferred that proper Leydig cell function is highly important
to male fertility (Dym 1994; Timpl 1996; Timpl and Brown 1996).

Sertoli cells
Interspersed between spermatogonial stem cells, Sertoli cells form physical contact with
the seminiferous epithelium’s basement membrane of type IV collagen and laminins
(Bawa 1963; Flickinger and Fawcett 1967). Sertoli cells play several important roles
during spermatogenesis, including: nutrition and support of germ cells; maintenance of
tight

junctions

for

seminiferous

tubule

compartmentalization

as

a

protected

microenvironment (Russell and Griswold 1993; Hess and Renato de Franca 2008);
release of spermatids into the lumen; secretion of growth factors; phagocytosis of
degenerating germ cells and of residual body cytoplasm shed by mature sperm (Van
Haaster, De Jong et al. 1992; Hess, Cooke et al. 1993; Sharpe, McKinnell et al. 2003). It
has been established in numerous studies that the number of Sertoli cells shows a strong
correlation with the maximal resulting sperm production (Kormano 1967; Setchell 2008).
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The tight junctions of Sertoli cells are critical to the integrity of the “blood-testis barrier”
that generates a specific and controlled environmental within seminiferous tubules of
post-pubertal mammalian testes (Witkin, Jeremias et al. 1996). This barrier creates an
immunologically-privileged compartment from which circulating antibodies and immune
cells are excluded (Teuscher, Wild et al. 1982; Yule, Montoya et al. 1988; Tung and
Teuscher 1995). Some reports have suggested that this barrier is incomplete, with the
result that germ cells occasionally pass the barrier and become subject to immunemediated attack (Russell 1978). Critically, this barrier must occasionally open to allow
developing spermatids into the seminiferous tubule lumen (Mruk and Cheng 2004), with
competing theories (reviewed in (Russell 1990; Chiarini-Garcia, Hornick et al. 2001))
debating the mechanism of this controlled traffic flow. As a critical step in sperm
maturation, this juncture represents a potential bottleneck target for contraception.

Mitosis in Spermatogonia
Spermatogonia are diploid (2n) cells comprising the earliest stages of spermatogenesis
as well as the fully undifferentiated spermatogonial stem cell population. In rodents,
electron

microscopy

evaluation

of

heterochromatin

distribution

in

developing

spermatogonia has resulted in sub-classification into four groups: undifferentiated (stem)
cells; differentiated type A (further sub-divided into A1-A4); intermediate (In); and type B
(B) (Brinster 2002; Ogawa, Ohmura et al. 2005; Oatley and Brinster 2006). Three such
classifications are used in humans: undifferentiated, type A differentiated, and type B (de
Rooij and Russell 2000; Aponte, van Bragt et al. 2005; Hofmann, Braydich-Stolle et al.
2005; Hess, Cooke et al. 2006; Oatley and Brinster 2006; Brinster 2007).
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The spermatogonial stem cell population is maintained by mitotic division, under which
one daughter cell differentiates while the other maintains the stem cell line. During
mitosis and maturation of differentiated spermatogonia, a relatively limited number of
factors (e.g. c-kit, Vitamin A) and proteins have been identified as initiators of key
signaling events (Clermont 1972). The number of regulated mitotic divisions varies
characteristically by species (Russell, Chiarini-Garcia et al. 2002), and it is during this
step in maturation that apoptotic loss of germ cells occurs, as a normal facet of
spermatogenesis in all mammals thus far investigated (Franca, Avelar et al. 2005; Luiz
Renato, Russell et al. 2006). For each differentiated type A spermatogonium, only 2-3
spermatocytes result from mitotic divisions capable of producing 8-12 (Hess and Renato
de Franca 2008), demonstrating that apoptotic culling of the developing spermatogonial
population is a critical regulator of gamete production. It has been proposed (Sharpe,
McKinnell et al. 2003) that programmed cell death may result from a density-dependent
limit on spermatogonial cell expansion established by the number of available Sertoli
cells, which would explain the observation that Sertoli cell population is a critical
determinant of maximal sperm production (Toshimori 2009).

Meiosis
The end products of spermatogonial maturation, spermatocytes, represent the beginning
of meiotic prophase I. Unlike female oocytes, which do not complete meiosis until
ovulation, spermatocytes progress through all steps of meiosis prior to spermiation
(Russell 1977; Weber, Russell et al. 1983). While in early stages they still rest on the
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basement membrane, as they develop spermatocytes move through the blood-testis
barrier of Sertoli cell junctions (as discussed earlier), entering the seminiferous tubule
lumen for further development (Franca and Cardoso 1998; Franca, Avelar et al. 2005).
During this process, spermatocytes also increase significantly in size as they begin
preparing the appropriate cellular contents necessary at the haploid spermatid stage
(Hess and Renato de Franca 2008).

During meiosis I, 4n primary spermatocytes divide to produce secondary 2n
spermatocytes, a relatively transient step in spermatozoan differentiation (Sassone-Corsi
1997; Eddy 2002). Meiosis II sees the division of secondary spermatocytes into haploid
(1n) round spermatids, which begin the profound biochemical and cytological
restructuring of spermiogenesis.

Spermiogenesis
Following meiosis, haploid round spermatids initiate a programmed system of robust
transcriptional activity, which has been extensively reviewed in the literature (Schmidt,
Ohbayashi et al. 1997). Dramatic increases in expression of transcription factors and
polymerases correspond with a need to rapidly produce necessary mRNAs and proteins
before chromatin is condensed in the tightly packaged nucleus of elongating spermatids
(Blendy, Kaestner et al. 1996; Nantel, Monaco et al. 1996).

While several testis-specific genes and isoforms play important roles, perhaps none are
so important as cAMP-responsive element modulator (CREM), a master transcription
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factor that regulates promoter function of many haploid spermatid genes (Steger,
Klonisch et al. 1999). In studies of infertile men with spermatogenesis arrest at the round
spermatid stage, CREM mRNA (Weinbauer, Behr et al. 1998) and protein (Braun,
Peschon et al. 1989) have both been reported to be severely reduced.

Concurrent with spermiogenesis-specific transcription, translation of resulting mRNAs is
regulated by the binding of cytoplasmic repressor proteins to the 3’-UTRs (Kwon and
Hecht 1993). A 17-nucleotide motif within the 3’-UTR of protamine mRNAs has been
pinpointed as a critical signaling element dubbed the “Z-box,” which coordinates
expression of genes involved in nuclear re-packaging (Steger, Failing et al. 2001) and
mediates temporary storage of transcripts in ribonucleoprotein (RNP) particles (Singh
and Rao 1987; Kundu and Rao 1995; Caron, Veilleux et al. 2001).

Nuclear Packaging
As haploid spermatids elongate and condense within the seminiferous tubules, remodeling of nuclear DNA allows for tighter compaction and protects against mutation.
Histones are the predominant protein binding genomic DNA in somatic cells, and they
play this role in male germ cells as well up to the end of meiosis. However, spermatid
elongation calls for the replacement of histones, first by transition proteins TP-1 and TP-2
(Bedford and Calvin 1974; Balhorn, Weston et al. 1984), and ultimately by highly basic
protamine proteins (Aitken and Krausz 2001; Aitken and Baker 2004). By binding to
protamines, genomic DNA is remodeled to a toroid “doughnut-like” structure that is
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resistant to the numerous stresses encountered during prolonged storage and journey to
the oocyte (Toshimori 2009).

Tail Formation
Chromatin remodeling to create the unique structure of the sperm head allows for
efficient and stable transport of haploid genomic material, accomplishing one of the
primary structural goals of sperm development. Head shapes vary somewhat across
species, being generally classified as: 1) sickle-shaped (falciform), common in rodents,
and 2) paddle-shaped (spatulate), seen in humans and many other species (Inaba 2011).

While there is some variation in the structure of the sperm head, evolution has more
strongly shaped the spermatozoan tail. Transit of genomic material (i.e. the sperm head)
within the female reproductive tract is the end goal of spermatogenesis, and the structure
of eukaryotic sperm flagellum is remarkably conserved across species (Baccetti and
Afzelius 1976), being a nearly universal approach to the challenge of male gamete
motility (Oko 1988).

Flagellum formation is based on the assembly of a cytoskeletal core, known as the
axoneme, which supplies structure and coordinates movement. Surrounding the
axoneme, robust mitochondrial development fuels waveform movement, while outer
dense fibers (ODFs) and a fibrous sheath (FS) form accessory cytoskeletal components
(Tesarik, Sousa et al. 1998). While ICSI has opened the door to fertilization using non-
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motile sperm (Pazour, Agrin et al. 2005), under normal conditions the building and
maintenance of these flagellar structures is essential.

Basic Research on Cilia & Flagella
From a structural perspective, the terms ‘cilia’ and ‘flagella’ are used interchangeably.
Function and formation have been so strongly conserved by evolution that these
structures are eukaryotic life’s sole option for a directed, rapidly moveable cellular
appendage.

Strong conservation of cilia structure and components has allowed for significant
molecular biology insight based on proteomic and gene mutation analyses in model
organisms, most notably the unicellular algae Chlamydomonas reinhardtii (overview in
(Lefebvre and Rosenbaum 1986)). The first critical ciliary genes were identified by
investigation of proteins markedly up-regulated following biochemical removal of cilia –
protein products produced after this disruption were hypothesized to be needed for
replacement of the missing organelle (Luck, Huang et al. 1982; Blacque, Cevik et al.
2008). From this initial set of candidate flagellar components, single-gene mutation
studies have highlighted several genes that are critical to ciliary motility; gene mutations
resulting in flagellar paralysis, misassembly within macromolecular complexes, or
perturbed interactions between large cytoskeletal components have been reported. This
extensive body of work (reviewed in (Wargo and Smith 2003)) has highlighted the
importance of the “9 + 2” axoneme, the core cytoskeletal structure that gives shape to
eukaryotic and allows for coordinated movement.
20

The “9 + 2” axoneme consists of a circular arrangement of 9 outer microtubule doublets
surrounding

two

central,

singlet

microtubules

dubbed

the

“central

pair.”

In

Chlamydomonas, these singlet microtubules are designated “C1” and “C2,” and each
possesses asymmetric projections to the surrounding doublets, allowing regulation of the
outer microtubules’ sliding movements (Dutcher and Lux 1989). In addition, the central
pair have direct connections to each other, allowing them to coordinate in their
manipulation of the outer doublets. Critically, this central pair is not present in the “9 + 0”
axoneme found in eukaryotic sensory, or “primary” cilia, and thus is deemed defining and
essential to ciliary motility.

Gene mutation and ultrastructural analyses in Chlamydomonas have allowed
characterization of specific domains of the axoneme, such that proteins can be assigned
in one of five groupings: 1) β-tubule projections, running between microtubules of a given
doublet; 2) Outer dynein arms, which extend from one doublet towards another along the
periphery of the axoneme; 3) Inner dynein arms, which extend from one doublet towards
another along the medial portion of the axoneme; 4) Radial spokes, which extend from
the outer doublets towards the central pair; 5) Central pair components, which facilitate
connections within one microtubule or between the pair (Duldulao, Li et al. 2010).

Ciliary dysfunction in disease
While their functions are not yet fully understood, cilia are found on almost all mammalian
cells (Nonaka, Tanaka et al. 1998; Nonaka, Shiratori et al. 2002). Though research
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efforts have previously examined ciliary functions in organisms such as Chlamydomonas
due to the relative simplicity of biochemical manipulations in such models, recent work
has focused more strongly on mammalian pathologies and development. It has been
shown that cilia in mice are essential for proper left-right asymmetry during embryonic
development (Chizhikov, Davenport et al. 2007; Davenport, Watts et al. 2007; Haycraft,
Zhang et al. 2007; Lehman, Laag et al. 2009; McDermott, Liu et al. 2010). The advent of
Cre-Lox conditional gene knockout technology has enabled targeted probing of ciliary
function in particular cell types, leading to the discovery of ciliary involvement in functions
such as hair follicle development, bone formation, mammary gland branching, central
nervous system morphogenesis, and satiety responses (Huangfu, Liu et al. 2003). These
somewhat unexpected observations have generated significant interest in the roles cilia
play not only as structural organelles but also as components of signal transduction. The
vertebrate Hedgehog pathway, which governs gene expression during development, is
dependent on cilia (Otto, Schermer et al. 2003; Simons, Gloy et al. 2005). Wnt signaling
is also affected by cilia function, thought in part due to the fact that the Wnt master switch
Inversin localizes to cilia (Hildebrandt, Benzing et al. 2011).

In humans, cilia have been associated with a numerous diseases, collectively termed
ciliopathies. The ubiquity of cilia expression suggests that cilia function is important in a
wide variety of cell types and tissues, though we will focus here on several important
examples (for a full review see (Wodehouse, Kharitonov et al. 2003; Olin, Burns et al.
2011)).
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Primary Ciliary Dyskinesia/Kartagener’s Syndrome
Primary Ciliary Dyskinesia (PCD) often manifests immediately in affected neonates,
reflecting that it is a disorder with origins during embryonic development. However,
diagnosis requires identification of a complex clinical presentation and subsequent TEM
(transmission electron microscopy) analysis of the patient’s cilia, making it likely that at
least some patients are missed and do not receive treatment (Zhu, Belmont et al. 2006).
Diagnosed by electron microscopy evidence of specific ciliary ultrastructural defects or
genetic testing revealing mutation in one of eight known genes, PCD has a somewhat
variable presentation centered around a trio of classic symptoms. Ciliary dysmotility
during embryogenesis commonly leads to situs inversus – complete left-right asymmetry
of the visceral organs – without apparent consequence. 50% of PCD patients have situs
inversus without observed clinical sequelae, while 6% have heterotaxy, abnormal
distribution of the viscera with paired organs (e.g. lungs, kidneys) mirrored rather than
uniquely “left” or “right” (Noone, Leigh et al. 2004; Kendig and Wilmott 2006). The most
common clinical symptom is severe respiratory distress, requiring neonatal oxygen
supplementation and leading to chronic respiratory infection. Ciliary defects lead to
reduced mucus clearance, creating a fertile ground for these repeated bacterial
infections. In adulthood, these early problems generally lead to bronchiectasis, a dilation
of the bronchial tree where constant inflammation limits airway adaptability, as in COPD
commonly suffered by long-term cigarette smokers (Afzelius 2004). Male PCD patients
additionally suffer from infertility in 50% of cases, owing to similar ultrastructural defects
in the sperm flagellum (Saeki, Kondo et al. 1984).
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Polycystic Kidney Disease
A strong association between cilia and Polycystic Kidney Disease (PKD) has been known
for decades (Yoder, Hou et al. 2002; Lin, Hiesberger et al. 2003; Otto, Schermer et al.
2003), with many PKD-related genes isolated to cilia (Torres, Harris et al. 2007). PKD
may result from autosomal dominant (AD) or recessive (AR) mutations, with the
autosomal dominant forms representing the most common lethal autosomal dominant
mutations in the US, at 1 in 1000 people affected (Pazour, Dickert et al. 2000; Yoder,
Hou et al. 2002; Sun, Amsterdam et al. 2004). The genes affected in AD PKD, PKD1 and
PKD2, are both important in differentiation and maintenance of renal tubules. Disruption
of these genes, and of cilia-related genes within the kidneys in general, leads inevitably
to kidney cyst formation (Kim and Walz 2007; Torres, Harris et al. 2007). These
pathological changes are not always detected in youth, as their clinical manifestations –
hypertension, abdominal pain, urinary tract infections – are non-specific (Alam and
Perrone 2010; Hogan and Norby 2010). Without treatment, however, PKD leads to endstage renal disease requiring dialysis and eventual kidney transplant, an outcome that
can be at least postponed with early detection and treatment (Ibanez-Tallon, Gorokhova
et al. 2002; Sapiro, Kostetskii et al. 2002; Banizs, Pike et al. 2005).

Hydrocephalus
Hydrocephalus is a pathological accumulation of cerebrospinal fluid within brain’s
ventricular spaces. Under normal conditions, cerebrospinal fluid is constantly moved,
resorbed and processed by ependymal cells, which form a ciliated epithelium
surrounding the ventricles. When ependymal cilia are unable to perform this task, fluid
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builds up within the ventricular spaces and forces expansion, compressing cerebral
tissue and raising intra-cranial pressure to unsafe levels (Inaba 2011).

The diversity of clinical pathologies deriving from cilia dysfunction demonstrates the
complexity of roles played by cilia in the human body. Addressing these clinical
challenges requires a better understanding of the basic molecular biology of the highly
conserved ciliary structure.

Spag16 and the Axoneme
The studies discussed here will focus primarily on a gene of the axoneme’s central
apparatus. The central apparatus contains at least 17 proteins (Randall, Warr et al. 1964;
McVittie 1972; Adams, Huang et al. 1981; Dutcher, Huang et al. 1984; Brokaw and Luck
1985), including products from six of the ‘pf’ genes, so designated because their loss in
Chlamydomonas reinhardtii results in paralyzed flagella: pf6, pf15, pf16, pf18, pf19, and
pf20 (Xu and Min 2011).

SPAG16, homologous to pf20 found in Chlamydomonas, produces a 631 amino acid
protein. The only identified conserved domains in the SPAG16 protein are seven WDrepeat domains located on the C-terminal half. These WD domains of approximately 40
amino acids in length give rise to a tertiary beta propeller structure, and are thought to
mediate macromolecular assembly through protein-protein interactions (reviewed in
(Zhang, Sapiro et al. 2002)). In all studied eukaryotic organisms, the pattern of protein
structure and function is highly conserved: the protein is located exclusively in the
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cytoplasm of ciliated cells, and specifically is found in the axoneme central apparatus; the
amino acid sequence is comprised of an N-terminal half with no known conserved
domains, and a C-terminal half with seven WD repeats.

In mice, the classic Spag16 protein product is known as SPAG16L, or “long” SPAG16, as
a second, shorter protein product has been identified and labeled SPAG16S (Strausberg,
Feingold et al. 2002). Whereas SPAG16L is found in all ciliated cells, SPAG16S was
isolated from testis, and has not been detected in any tissue outside the male
reproductive system to date. The amino acid sequences in both proteins are exactly the
same, except that SPAG16S lacks the N-terminal half of SPAG16L, having instead only
the portion with WD repeats. Unlike SPAG16L, SPAG16S is found in the nucleus (as well
as the cytoplasm), and is enriched in specific sub-nuclear clusters.

While SPAG16S has been most extensively characterized in mice, including the work
presented here, we hypothesize that expression of SPAG16S represents an evolution of
the Spag16 gene in mammals. We have previously identified a putative SPAG16S
promoter and 5’-UTR in humans [GenBank: EF591776.1], and the identified rat version of
SPAG16 – isolated from testis – resembles murine SPAG16S (Clark 2007).

Phenotypes of Spag16 disruption
Though it has been one of the major goals of the field of male reproduction research for
decades, a reliable male germ cell model line has yet to be established (reviewed in
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(Zhang, Kostetskii et al. 2006)). As a result, studies of gene function are largely carried
out using transgenic mouse models.

SPAG16L
We have previously reported that male mice with a gene mutation disrupting production
of SPAG16L (but not SPAG16S) are infertile, with reduced sperm counts and profound
disruption of sperm motility, demonstrating the importance of SPAG16L to sperm flagellar
function (Lesich, Zhang et al. 2010). Interestingly, SPAG16L-deficient mice do not display
signs of hydrocephalus, bronchial abnormality, or kidney function failure. Additionally, the
axoneme ultrastructure of SPAG16L-deficient mice appears normal when examined by
transmission electron microscopy. However, recent studies have demonstrated that
sperm flagella from SPAG16L-deficient mice show greatly reduced bending during
attempted waveform movement, and that molecular responses to calcium are
significantly diminished (Zhang, Kostetskii et al. 2004). In light of these recent data, we
hypothesize that the role of SPAG16L in the axoneme is essential for coordinated
movement within the structure, rather than for structural assembly. The critical point,
however, is that loss of SPAG16L specifically affects flagellar motility, whereas
spermatogenesis is largely undisturbed.

SPAG16L and SPAG16S
Disruption of both isoforms of SPAG16 results in a severe phenotype that manifests even
in the chimeric state of transgenic animal breeding: spermatogenesis is significantly
disrupted, and the flagellar axoneme is significantly disrupted (Zhang, Kostetskii et al.
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2004). Notably, the Spag16 mutant transgene was never transmitted by fertile male
carriers, suggesting that sperm carrying the mutant copy of the gene were unable to
complete spermatogenesis and/or fertilize a female ovum. Haploinsufficiency is rarely
encountered in male reproduction, as such profound defects are unable to be passed to
offspring and thus do not remain in the population. The difference between the flagellarspecific disruption seen with loss of SPAG16L alone and the spermatogenetic arrest
observed with disruption of both isoforms suggests a fundamental role for Spag16 in
sperm development and function. We hypothesize that the localization of SPAG16S in
the nucleus is necessary for the coordination of molecular signals that direct the progress
of spermatogenesis.

SPAG16 protein interactors
As SPAG16 proteins lack identifiable effector domains, they are believed to function
through interaction with other proteins, likely through the assembly of macromolecular
complexes. We have previously reported that SPAG16S interacts with MEIG1, a 10-kDa
protein initially believed to play a role in regulation of meiosis (Zhang, Shen et al. 2009).
We have recently found that male mice deficient in MEIG1 are infertile due to arrest of
spermatogenesis at the stages of elongation and condensation (Salzberg, Eldar et al.
2010), a conclusion which has been reached by an independent group as well
(Stirnimann, Petsalaki et al. 2010). While the mechanism for spermatogenesis arrest in
the absence of MEIG1 cannot be conclusively linked to SPAG16S, this finding provides
additional support for the hypothesis that a SPAG16S-related pathway is necessary to
spermatogenesis and independent of the structural role of SPAG16L.
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Both SPAG16S and SPAG16L most likely exert their influence through interaction with
several different effector partners. WD domains have been referred to as among the
most promiscuous interactors (Lau, Bachorik et al. 2009), as they are commonly
retrieved candidates in protein interaction studies. Further, it has recently been reported
that at least some WD domains confer RNA binding specificity as well (Luck 1984; Porter
and Sale 2000). The diversity of potential interaction partners means that relatively little is
known about the evolution and function of the SPAG16 gene.

The present work will discuss the roles of SPAG16 in mammals by examining: the sublocalization of murine SPAG16S; the functional roles of the SPAG16S protein; the status
of the SPAG16 gene in azoospermic human subjects.
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Chapter 2: Spag16, an Axonemal Central Apparatus Gene, Encodes a Male Germ
Cell Nuclear Speckle Protein that Regulates SPAG16 mRNA Expression

Abstract
Spag16 is the murine orthologue of Chlamydomonas reinhardtii PF20, a protein known to
be essential to the structure and function of the “9 + 2” axoneme. In Chlamydomonas, the
PF20 gene encodes a single protein present in the central pair of the axoneme. Loss of
PF20 prevents central pair assembly/integrity and results in flagellar paralysis. Here we
demonstrate that the murine Spag16 gene encodes two proteins: 71 kDa SPAG16L,
which is found in all murine cells with motile cilia or flagella, and 35 kDa SPAG16S,
representing the C terminus of SPAG16L, which is expressed only in male germ cells,
and is predominantly found in specific regions within the nucleus that also contain SC35,
a known marker of nuclear speckles enriched in pre-mRNA splicing factors. SPAG16S
expression precedes expression of SPAG16L. Mice homozygous for a knockout of
SPAG16L alone are infertile, but show no abnormalities in spermatogenesis. Mice
chimeric for a mutation deleting the transcripts for both SPAG16L and SPAG16S have a
profound defect in spermatogenesis. We show here that transduction of SPAG16S into
cultured dispersed mouse male germ cells and BEAS-2B human bronchial epithelial cells
increases SPAG16L expression, but has no effect on the expression of several other
axoneme components. We also demonstrate that the Spag16L promoter shows
increased activity in the presence of SPAG16S. The distinct nuclear localization of
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SPAG16S and its ability to modulate Spag16L mRNA expression suggest that SPAG16S
plays an important role in the gene expression machinery of male germ cells. This is a
unique example of a highly conserved axonemal protein gene that encodes two protein
products with different functions.

Introduction
The “9+2” axoneme, a cytoskeletal structure found in motile cilia and flagella, is
composed of nine outer doublet microtubules linked to a central microtubule pair via
dynein arms to form a motor complex allowing coordinated force generation (Adams,
Huang et al. 1981; Dutcher, Huang et al. 1984). The central pair of microtubules is critical
to the integrity and the motility of this structure. One essential element of the central
apparatus, PF20, was first identified in Chlamydomonas reinhardtii (Smith and Lefebvre
1997; Smith and Lefebvre 1997), and has since been shown to exhibit strong
conservation amongst a wide variety of organisms and ciliated cell types (Zhang, Sapiro
et al. 2002).

We have reported that the murine orthologue of PF20, Spag16, encodes two distinct
proteins: SPAG16L, which is a component of the axoneme central apparatus (Zhang,
Kostetskii et al. 2004), and SPAG16S, a smaller protein representing the WD repeat
region of SPAG16L, identified only in male germ cells (Zhang, Kostetskii et al. 2004).
Chimeric mice carrying a mutation that disrupted the Spag16 gene at a locus shared by
transcripts encoding both SPAG16L and SPAG16S displayed a phenotype of
haploinsufficiency; the mutant allele was never transmitted to offspring by chimeric males
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(Zhang, Kostetskii et al. 2006). Furthermore, these mice exhibited significant germ cell
loss at the round spermatid stage. In contrast, transgenic mice homozygous for a
deleterious mutation in the SPAG16L-specific region of the gene were infertile, with
normal spermatogenesis but resulting in sperm showing marked motility defects despite
an axonemal structure devoid of significant ultrastructural defects (Lamond and Spector
2003). The deficits observed with ablation of both SPAG16 isoforms, not accounted for
by loss of SPAG16L alone, suggest that SPAG16S may play a critical and previously undescribed role in spermatogenesis.

We show here that SPAG16S is localized to nuclear subdomains called nuclear
speckles. Nuclear speckles are non-nucleolar domains within the nucleus that contain
splicing factors as well as transcription factors, RNA processing units, and structural
scaffold proteins (reviewed by Lamond and Spector (Ricciardi, Kilstrup-Nielsen et al.
2009; Hu, Plutz et al. 2010)). Though not generally believed to be centers of active
transcription, speckles have been implicated as compartments that can provide splicing
factor contents to active transcription sites (Shopland, Johnson et al. 2003). Speckles are
enriched in SC35, which is used as a marker for these distinct domains. SC35 domains
have been linked to the development of a cell-type specific genomic organization and to
the mapping of distinct “euchromatic neighborhoods” (Zhang, Kostetskii et al. 2006;
Zhang, Zariwala et al. 2007). Though nuclear speckles have been shown to play central
roles in management of gene expression, their role in male germ cell differentiation has
not been previously reported.
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Results
Identification of the 5' UTR of mouse SPAG16S
To identify the 5' UTR of Spag16S mRNA, 5' RACE was performed with a primer located
close to the 3' end of mouse Spag16L mRNA (Fig. 2-1A). Two PCR products were
amplified (Fig. 2-1B), and each one was cloned into the pCR2.1 Topo TA vector
(Invitrogen). 10 clones of each PCR product were sequenced after vector insertion,
demonstrating that Spag16S sequence is identical to that of Spag16L exons 11-17, with
the addition of a 5' untranslated exon, not found in Spag16L, named exon 10a (Fig. 21C). This exon 10a is located in the middle of intron 10 of the Spag16 gene,
approximately 50 kb from Spag16L exon 10 and 50 kb from Spag16L exon 11.
Sequencing results demonstrated multiple potential transcription start sites for Spag16S
transcription; the exon is situated in a TC-rich locus that lacks a standard TATA box (Fig.
2-10).

Spag16S message is expressed only in the testis and male germ cells
SPAG16L is present not only in testis, but also in other murine tissues containing cells
with a “9 + 2” axoneme structure (Zhang, Kostetskii et al. 2004). Primer sets were
designed to specifically amplify Spag16L (exons 2-4) or Spag16S (exons 10a-12) (Fig. 21C). In adult mice, Spag16L mRNA was detected in testis, brain, lung, and oviduct;
however, Spag16L mRNA was not detected in heart tissue (Fig. 2-1D), which does not
contain cells with motile cilia. Spag16S mRNA was detected only in testis (Fig. 2-1D),
and in further testing was not detected in kidney, liver, or spleen. Spag16S expression
also appears to be exclusive to males, rather than being a general germ cell factor, as
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Spag16S mRNA was never detected by PCR using up to 10 oocyte equivalents in qPCR
amplification of up to 40 cycles.

Expression pattern of SPAG16S during the first wave of spermatogenesis
RNA and protein were isolated from mouse testis at 6, 8, 12, 16, 20, 30, and 42 days
after birth. cDNA was generated by RT-PCR, and testis extracts were probed by PCR for
Spag16 isoform expression using specific primers. Spag16S mRNA was detected at day
16, whereas Spag16L mRNA was detected later, at day 20 (Fig. 2-2B). Western blotting
was performed as well, using a polyclonal antibody that recognizes both isoforms of
SPAG16 (Zhang, Shen et al. 2008). Consistent with PCR results, SPAG16S protein was
detected at day 16, while SPAG16L was detected at day 20 (Fig. 2-2C). Additionally,
both isoforms appeared to be up-regulated at days 30 and 42, consistent with the end of
the first wave of spermatogenesis.

The immunoreactive bands other than 71 kDa

SPAG16L and 35 kDA SPAG16S seen on days 20, 30 and 42 may represent posttranslational processing of SPAG16, including proteolytic cleavage of SPAG16L and
phosphorylation or other modifications (Smith and Lefebvre 1997; Zhang, Tang et al.
2007; Lesich, Zhang et al. 2010).

Sub-cellular localization of SPAG16 isoforms
Cytoplasmic and nuclear fractions of adult mouse testis were isolated, and equivalent
amounts of protein from each were probed by Western blot using the C-terminal SPAG16
antibody that recognizes both isoforms. SPAG16L was detected abundantly in the
cytoplasm, while SPAG16S was detected in both cytoplasm and nucleus (Fig. 2-3A). The
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cytoplasmic localization of SPAG16L is consistent with its identified role as a structural
component of the “9 + 2” axoneme (Zhang, Kostetskii et al. 2006). In order to further
characterize the sub-cellular localization of SPAG16S, immunohistochemistry was
performed on tissue slices from adult mouse testis. Using the C-terminal SPAG16
antibody, the strongest signal was detected from discrete structures within the nucleus
(Fig. 2-3B, see arrows). Protein expression was most clearly visualized approximately
halfway through spermatogenesis, at the round spermatid stage.

A mixed population of mouse male germ cells was prepared from adult mouse testis, and
immunocytochemistry performed to allow for single-cell imaging to compare with
immunohistochemistry results. Consistent with previous data, the C-terminal SPAG16
antibody produced the strongest fluorescence in discrete sub-nuclear, non-nucleolar
structures, approximately 2-6 per cell (Fig. 2-4). The N-terminal SPAG16 antibody,
recognizing SPAG16L only, produced an exclusively cytoplasmic signal. Germ cells from
SPAG16L-KO mice (Bastin, Pullen et al. 2000; Kohl and Bastin 2005) were isolated and
immunolabeled as well, demonstrating the specificity of the antibodies (Fig. 2-4). As in
wild-type

germ cells, the C-terminal SPAG16 antibody produced sub-nuclear

immunolabelling, which we interpret to represent SPAG16S, while the N-terminal
antibody produced no signal, as expected following the deletion of SPAG16L.

SPAG16S co-localizes with nuclear speckles
In order to characterize the discrete nuclear structures identified by immunohistochemical
analysis of SPAG16S localization, wild-type germ cells were co-immunolabeled with both
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the C-terminal SPAG16 antibody and a monoclonal antibody directed against SC35, a
marker for nuclear speckles. SC35 and SPAG16S signals strongly overlapped (Fig. 25A). They were determined to have a significant co-localization (Fig. 2-5B – Pearson's
coefficient = 0.40; p = 0.0079; N = 43). Analysis demonstrated that 79% of SC35 signal
co-localized with SPAG16S, while 44% of SPAG16S signal co-localized with SC35; in
other words, most SC35-containing domains also contained SPAG16S, but SPAG16S
had a wider distribution as well.

Role of SPAG16S in SPAG16L expression
Given the timing of SPAG16S expression (Fig. 2-2B-C) and its specific nuclear
localization (Fig. 2-3 – 2-5), it was hypothesized that SPAG16S might play a role in
regulation of gene expression. Mixed mouse male germ cells were isolated from testis
and cultured, with exposure to a SPAG16S-transducing adenovirus or a control
adenovirus. Following 48 hour culture, RNA was isolated for analysis of gene expression,
and several highly conserved axoneme genes were assessed for mRNA levels. While
Spag6, Spag17, and Akap4 were unaffected, Spag16L message level was significantly
increased (Fig. 2-6).

SPAG16S was also shown to induce SPAG16L expression in BEAS-2B human bronchial
epithelial cells. This cell line does not express SPAG16L at levels detectable by qPCR or
Western blotting (data not shown). Expression of SPAG16S was induced in cultured
BEAS-2B cells by plasmid (Fig. 2-7A) or adenovirus (Fig. 2-7B), and primers specific for
human SPAG16L were used to measure transcript levels, which were normalized to 18S
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rRNA. Immunocytochemistry performed with the C-terminal SPAG16 antibody confirms
that SPAG16 proteins are expressed in the transduced cells, but not in cells exposed to a
control adenovirus (Fig. 2-7C). Following adenoviral transduction, protein was also
isolated from cultured BEAS-2B cells, and SPAG16L was demonstrated by Western blot
to be present in cells transduced with SPAG16S adenovirus, but not cells transduced
with a control adenovirus (Fig. 2-7D).

Following the observation that SPAG16L protein and mRNA levels were increased in the
presence of SPAG16S, Spag16L promoter activity was tested as well. While other
axoneme gene promoters (Spag17, Spag6) did not show significantly altered activity,
SPAG16L promoter activity was significantly higher in the presence of plasmid-induced
SPAG16S when compared to co-transfection with a control empty vector plasmid (Fig. 28).

In order to identify a specific region within the SPAG16L promoter showing increased
activity with SPAG16S expression, luciferase plasmid constructs were made with
progressively shorter sequences of the SPAG16L proximal promoter, ranging from 2 kb
to 100 bp upstream of the transcription start site. Promoters ranging from 2 kb to 200 bp
upstream of the transcription start site demonstrated significantly higher activity when cotransfected with a SPAG16S plasmid, but a 100 bp upstream SPAG16L promoter did not
show increased activity in the presence of SPAG16S plasmid (Fig. 2-9).
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Discussion
Flagella and cilia are strongly conserved structures, having maintained a highly specific
structure and function throughout eukaryotic life, from unicellular protists to mammals
(Inaba 2003; Inaba 2007). It has been suggested that molecular structures of each
component in the axoneme are not always conserved, but protein domains within
axoneme structures are preferably conserved, allowing for overall morphological and
functional conservation (Kleene 1996; Fajardo, Haugen et al. 1997). Although the
Chlamydomonas pf20 gene encodes only one transcript, its mouse orthologue encodes
two mRNAs for two proteins, SPAG16L and SPAG16S, each of which have conserved
WD-repeat domains. To study the expression pattern of the two mRNAs and proteins,
testicular total RNAs and proteins were isolated from mice at different ages. Given that
Spag16S harbors an untranslated exon 10a – which is not present in Spag16L – a
Spag16S-specific forward primer was designed to selectively amplify the Spag16S
transcript. Both SPAG16S mRNA and protein are expressed earlier than SPAG16L
message and SPAG16L protein. For both SPAG16L and SPAG16S, mRNAs and
proteins appear simultaneously (SPAG16S at day 16, followed by SPAG16L at day 20),
suggesting that there is no translation delay (Zhang, Tang et al. 2007). Furthermore,
Spag16L is expressed in other tissues, such as brain and lung, all of which contain motile
cilia (Reddi, Flickinger et al. 1999; Eddy 2002; Reddi, Shore et al. 2002), but Spag16S is
expressed only in the mouse testis, indicating that Spag16S is a testis-specific gene
product. Moreover, Spag16S sequences identified in GenBank in a variety of mammalian
species (Mouse: NM_025728.3; Rat: BC158602.1; Human: EF591776.1) have each
been detected from testis samples.
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Testis-specific genes can be grouped into three clusters. Homologous genes are those
which are expressed only in spermatogenic cells, but which are closely related to genes
expressed in somatic cells, and are often members of gene families. Unique genes are
those without significant similarity to any other genes in the genome. Variant transcripts
are transcribed from genes also expressed in somatic cells but are often smaller or larger
than their somatic cell counterparts. They are the result of the utilization of one or more
alternate transcriptional start sites, splice sites, or polyadenylation signals. Since
spermatogenesis is a highly coordinated process, different genes are expressed during
the three different stages of spermatogenesis, and gene expression can be used as a
tool to assess progression through the stages of spermatogenesis (Wang, McCarrey et
al. 2001). There are genes that have been shown to be expressed solely in the mitotic
phase (spermatogonia) (Eddy and O'Brien 1998). Some are expressed during the meiotic
phase (spermatocyte) (Beissbarth, Borisevich et al. 2003) and others during the postmeiotic phase in spermatids (Zhang, Kostetskii et al. 2006). Some of these genes are
expressed solely in germ cells, while others are also expressed in somatic cells as well.

It appears that the Spag16S transcript is unique, as no related transcripts were identified
in somatic cells. It is unlikely to be a spliced isoform of the Spag16L transcript, since it is
detected in testis of mice homozygous for a mutation that ablates the Spag16L mRNA
(Strausberg, Feingold et al. 2002). Similarly, evidence suggests that the SPAG16S
protein is not a processed form of SPAG16L, since the SPAG16S protein is present in
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SPAG16L-deficient mice, and the expression of SPAG16S occurs earlier than SPAG16L
(Figure 2-2).

The mouse Spag16S 5’-UTR and upstream putative promoter region are highly
conserved in rat (see Fig. 2-10). It is worth noting that only a single Spag16 transcript has
been identified in rat (BC158602.1), and its coding sequence corresponds to the region
shared by both mouse Spag16 isoforms. However, the rat Spag16 mRNA includes a 410
bp 5’-UTR that is nearly identical to the mouse exon 10a plus its immediate upstream
genomic sequence (Zhang, Kostetskii et al. 2006). Moreover the rat Spag16 transcript
was identified specifically in testis, leaving open the possibility that a Spag16L-like
transcript may be likely to exist in testis and other tissues.

Different subcellular localization of SPAG16L and SPAG16S suggests that the two
proteins play different roles. This was subsequently confirmed by two knockout models
generated previously in our laboratory. SPAG16L regulates ciliary motility (Zhang,
Kostetskii et al. 2004), while SPAG16S controls spermatogenesis (Escalier 2006). Loss
of both SPAG16 isoforms produced a non-transmitted allele and led to significant arrest
and cell death at the round spermatid stage in chimeric male mice carrying the mutant
gene. While homozygosity for a SPAG16L-deletion mutation produced male infertility, the
mutant allele was transmitted in the chimeric and heterozygous states, and the
perturbation of spermatogenesis observed with total SPAG16 knockout was not seen. It
has been observed that genetic mutations contributing to male infertility are often
discovered to take effect through unexpected or unexplored cellular pathways. Thus,
40

while Spag16 is known to be important to the axoneme through SPAG16L, the existence
of an additional protein of unknown – and potentially more essential – function is
consistent with published findings (Neer, Schmidt et al. 1994; Smith, Gaitatzes et al.
1999).

Both SPAG16L and SPAG16S contain 7 WD-repeat domains, semi-conserved 40 amino
acid-regions ending with tryptophan-aspartate (W-D). These regions are known to
mediate protein-protein interactions by giving rise to a ß–propeller tertiary structure. By
interacting with effector partners, WD repeat proteins have been shown to play important
roles in an extensive variety of cellular activities, including cell division, gene
transcription,

mRNA

modification,

and

transmembrane

signaling

(reviewed

in

(Gallenberger, Meinel et al. 2011)). More recently, it has been reported that WD domains
may also mediate specific processing of small RNAs (Lau, Bachorik et al. 2009) and
direct binding of RNAs (Caceres, Misteli et al. 1997; Lallena and Correas 1997), further
diversifying the range of potential roles these structures can play in eukaryotic cells.
Because SPAG16S contains no obvious nuclear localization signals, its importation into
the nucleus may be effected by its association with other proteins including transcription
factors or nuclear speckle components.

We have demonstrated that while SPAG16L is exclusively in the cytoplasm of male germ
cells – consistent with its structural role in the axoneme – SPAG16S is present in both
nucleus and cytoplasm, and exhibits enhanced sub-localization within the nucleus. A
monoclonal antibody directed against SC35, a canonical marker for nuclear speckles
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(Lamond and Spector 2003), maps to the same nuclear regions that show enhanced
SPAG16S signal, suggesting that SPAG16S is located in nuclear speckles of male germ
cells, specifically at the round spermatid stage. Nuclear speckles are enriched in splicingrelated factors, and though they are not active centers of transcription (Brown, Green et
al. 2008; Hu, Kwon et al. 2008; Takizawa, Gudla et al. 2008; Zhao, Bodnar et al. 2009),
they have been shown to associate with active alleles (Spector, O'Keefe et al. 1993).

The role of nuclear speckles has yet to be described in mammalian spermatogenesis.
Though somatic cells nuclei contain 30-50 nuclear speckles, these structures are known
to condense following inhibition of transcription (Marchler-Bauer and Bryant 2004;
Marchler-Bauer, Lu et al. 2009); thus, the presence of only a few, larger speckles at the
round spermatid stage is consistent with the down-regulation of transcription during
sperm development. The unique nature of transcript and protein packaging during
nuclear condensation in spermatogenesis suggests the intriguing possibility that nuclear
speckles may play a distinct role in this process, and that SPAG16S may be a germ cellspecific factor necessary to guide this process.

SPAG16L mRNA and SPAG16L protein are up-regulated in vitro in the presence of
SPAG16S, suggesting that one role of SPAG16S involves regulation of the SPAG16L
isoform. These data are consistent with the observation that SPAG16L appears after
SPAG16S. We have also shown that the Spag16L promoter displays significantly
enhanced activity in the presence of SPAG16S.
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While we cannot rule out the possibility that SPAG16S is involved in SPAG16L regulation
through transcript processing events in nuclear speckles, these data strongly suggest
that a primary responsibility of SPAG16S is activation of SPAG16L transcription. Since
SPAG16S does not have an identified DNA-binding domain, it is unlikely to directly bind
the Spag16L promoter, but rather to effect this interaction by binding with one or several
protein partners. WD-repeat proteins are known to interact dynamically and reversibly
with multi-protein complexes, thus identification of SPAG16S-associating structures
presents a challenging but enticing area for future study.

While the in vitro promoter studies presented here strongly suggest a role for SPAG16S
in direct transcription of SPAG16L, future studies should seek to clarify the exact role of
SPAG16S in male germ cell transcript regulation, as the speckle localization of the
protein is more suggestive of a role in transcript processing. Such studies would also
clarify the role of nuclear speckles in round spermatids, as these structures are of
particular interest given the unique transcriptional requirements of round spermatids as
spermiogenesis takes place.

The 2kb SPAG16L proximal promoter was also assessed for putative binding sites of
other transcription factors using ConSite open source software, but current transcription
factor lists are limited in scope, particularly regarding germ cell-specific relevant
transcription factors, some of which are known to activate the SPAG16L promoter. Given
currently limited in silico capabilities, we believe that further molecular data are required
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before generalized transcription factor prediction is a sufficiently reliable in a germ cell
system.

In summary, SPAG16S is a testis-specific protein found in nuclear speckles that appears
to regulate spermatogenesis by controlling testis-specific target gene expression, one of
the target genes being Spag16L. Thus, the murine Spag16 gene has dual functions. It
encodes a structural protein at the axoneme, which is essential for sperm motility, and a
nuclear speckle-associated factor that regulates Spag16L gene expression. To the best
of our knowledge, this is the first example of a gene’s evolution conferring the ability to
regulate its own, conserved products.

Materials and Methods
Ethics Statement
No human or primate subjects were used in this work. All rodent work was approved by
Virginia Commonwealth University’s Institutional Animal Care & Use Committee (protocol
permit #AM10297) in concordance with all federal and local regulations regarding the use
of non-primate vertebrates in scientific research.

Research animals were humanely

housed and care was taken to prevent undue distress.

5’ Rapid amplification of cDNA ends (5’ RACE)
5’ RACE was carried out to define the 5’ non-translated region sequence and
transcriptional start site of the mouse Spag16S mRNA using mouse Marathon cDNA
amplification kit (Clontech) according to the manufacturer’ instructions. Briefly, a reverse
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primer

was

designed

within

the

coding

region

of

Spag16

(5’-

AGAAGCCACGAAGTCACCACAGGAGT-3’) and used together with the Marathon cDNA
adaptor primer to generate 5’-RACE products. The smaller product was cloned into the
pCR2.1-TOPO TA vector and subjected to DNA sequence analysis.

Conserved domain analysis
Mouse SPAG16S (NP_080004.1) and SPAG16L (NP_083436.2) protein sequences were
analyzed using NCBI Conserved Domains tool (Zhang, Sapiro et al. 2002; Zhang,
Kostetskii et al. 2004).

Antibodies
SPAG16-specific antibodies directed against the common C-terminus (SPAG16L amino
acids 330-639) and the SPAG16L-specific N-terminus (amino acids 1-212) have been
previously described (Abramoff, Magelhaes et al. 2004).

-tubulin (cytoplasmic marker)

and Lamin B (nuclear marker) were from Santa Cruz Biotechnology. SC35 was
purchased from Sigma-Aldrich.

Microscopy and colocalization analysis
Confocal laser scanning microscopy was performed using a Leica TCS-SP2 AOBS
(Leica Microsystems). Colocalization calculations were performed using Volocity
Quantitation software (Perkin-Elmer).
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Mixed germ cell preparation
A male adult mouse was anesthetized and euthanized, and the testis decapsulated and
placed in 5 mL PBS. Collagenase IV (Sigma-Aldrich) was added to a final concentration
of 0.5 mg/mL and DNase I (Sigma-Aldrich) to a final concentration of 1.0 mg/mL. Testis
solution was incubated 30 min at 32° C to dissociate cells, and then centrifuged 5 min at
1000 rpm. Cells were fixed by 15 min incubation in 1% paraformaldehyde/PBS at room
temperature, and then washed three times with PBS. Prior to plating, cells were resuspended in 12.5 mL PBS and 50 µL of cell suspension was spread on SuperFrost/Plus
microscope slides (Fisher Scientific) and allowed to air-dry. Slides were used
immediately for immunocytochemistry or stored at -80° C until use.

Cell fractionation into nuclei and cytoplasm
Freshly isolated mouse male germ cells (see germ cell slide preparation protocol) were
separated into nuclear and cytoplasmic fractions using a Nuclear/Cytosol Fractionation
Kit (BioLine, Inc.) per manufacturer’s instructions.

Western blotting analysis
Equal amounts of protein (50 µg/lane) were heated to 95° C for 10 minutes in 4X sample
buffer, loaded onto 10% sodium dodecyl sulfate-polyacrylamide gels, electrophoretically
separated, and transferred to PVDF membranes. The membranes were blocked and
then incubated with primary antibody at 4° C overnight. After being washed, the blots
were incubated appropriate HRP-conjugated secondary antibody (GE Healthcare UK) for
1 hour at room temperature. After washing, protein was detected with Super Signal
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Chemiluminescent Substrate (Pierce). Densitometry performed using ImageJ (Horowitz,
Zhang et al. 2005)

Immunocytochemistry and immunohistochemistry
Slides were first blocked 1 hour at room temperature with 10% goat serum/PBS.
Following overnight incubation with primary antibody (diluted 1:100-300 in blocking
medium) at 4º C, slides were washed with PBS and incubated 1 hour at room
temperature with Alex 488-conjugated anti-mouse IgG secondary antibody (1:500;
Jackson ImmunoResearch Laboratories) or Cy3-conjugated anti-rabbit IgG secondary
antibody (1:1000; Jackson ImmunoResearch Laboratories). Following secondary
antibody incubation, slides were washed in PBS and sealed using VectaMount with DAPI
(Vector Laboratories).

Generation of adenovirus to express SPAG16S
Adenovirus expressing SPAG16S (AdSpag16s) was generated with AdEasyTM
Adenoviral Vector System (Stratagene) following the instruction manual. Briefly, mouse
Spag16S cDNA was subcloned into adenovirus shuttle vector pShuttle-CMV and the
cDNA was transferred into pAdEasy-1 virus genome by means of homologous
recombination in an adenovirus packaging cell line HEK-293 cells (ATCC; Manassas,
VA). The expression of SPAG16S was tested with western blotting using proteins from
COS-1 cells (ATCC) and BEAS-2B cells (ATCC) infected with AdSpag16S or control Ad
virus. The AdSpag16S and control Ad virus were amplified and titered in the
Macromolecule Core Facility of Virginia Commonwealth University.
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Generation of plasmid to express SPAG16S
Mouse testis cDNA was used as a template to amplify Spag16S sequence by PCR.
Amplified PCR product was cloned in a pCR2.1 Topo TA vector for sequencing, then
released by restriction enzyme digestion and ligated in a pTarget vector. Primers used:
Forward (BamHI): 5’-GGATCCCCTGTAGATATGCAACCAGATCC-3’; Reverse (SalI): 5’GTCGAC GCTGATCAGATCCACAACCGAATG-3’

RT-PCR and real-time PCR
Total RNA was isolated from cultured cells and indicated tissues with Trizol (Life
Technologies, Inc., Grand Island, N.Y.), the RNA was reversed transcribed, and the
cDNAs were used for RT-PCR or real-time PCR.

For real-time PCR, cDNAs from BEAS-2B cells transfected with pcDNA3 or
Spag16S/pcDNA3 plasmids or infected with AdSpag16S or control Ad virus were utilized
for PCR. Primers were designed for detection of human SPAG16L using the software
from GeneScript Corporation (http://www.genscript.com/). Real-time PCR reactions were
carried out using the 2X SYBR green master mix (BioRad). Akap4, Spag17, and Spag6
primers have been previously reported (Horowitz, Zhang et al. 2005).
(human) SPAG16L – Forward: 5’-TTCAGACTGCTGCTTCCATC-3’; Reverse: 5’TCGCCTGTACATAGATCCCA-3’
(mouse) Spag16L – Forward: 5’-AGCAAGCCAGAGACATCCAT-3’; Reverse: 5’CCAGAAATCTTCCCAACAGC-3’
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(mouse) Spag16S – Forward: 5’-CTCTGACACAATGAGTATGG-3’ (exon 10a); Reverse:
5’-CTACAGGAAATTCTGAATCC-3’ (exon 11)
18S

–

Forward:

5’-GGCCCTGTAATTGGAATGAGTC-3’;

Reverse:

5’-

CCAAGATCCAACTACGAGCTT-3’

Luciferase promoter activity assay
Promoter plasmids were designed using a PGL3 basic vector (Promega). For each
experiment, BEAS-2B cells were co-transfected with empty vector or promoter plasmid
and a control (pTarget - Promega) or test (SPAG16S) plasmid using Fugene 6
transfection reagent (Roche) then cultured 48 hours. Cells were lysed using 1X passive
lysis buffer according to manufacturer’s instructions (Promega) and luciferase activity
measured using freshly-prepared reagents. Data are represented as relative fold
difference from PGL3 control promoter co-transfected with control pTarget vector
plasmid.

Generation of promoter constructs for promoter function assays
Promoter sequences were amplified by PCR from mouse DNA and sub-cloned in a PGL3
basic vector after sequences were confirmed by first cloning in a Topo Vector (Invitrogen)
for sequence analysis. Primers were designed to specifically amplify regions upstream of
the transcription start site (Fig. 2-9). 2 kb, 1.5 kb, and 0.5 kb promoter constructs were
previously generated in our lab (Boivin, Bunting et al. 2007). 0.3 kb, 0.2 kb and 0.1 kb
promoter constructs were generated as described using a common reverse primer (5’-
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CTCGAGGCTTGCAACTGCGGCCCCTCGGTGCC-3’)

with

the

following

forward

primers:
0.3 kb Spag16L –5’-GGTACCCGCAAGCAAGCAAGCAAGCAAGCAAGC-3’
0.2 kb Spag16L – 5’-GGTACCGGTTCTGGGCTTCAGGTCTGCAGTCC-3’
0.1 kb Spag16L – 5’-GGTACCCGCTTGACCGGGGCCTTTTGGTGC-3’

Statistical Analysis
Statistical analyses were performed using Student-Newman-Keuls post-hoc analyses
with a significance level of α = 0.05.
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Figure 2-1. The murine Spag16 gene encodes two transcripts. Spag16L is
expressed in all tissues with ciliated cells, while Spag16S is expressed only in
testis
(A) 5' RACE was performed with a primer as indicated. (B) Products of 5' RACE
separated on 1% agarose gel. (C) Exon map of Spag16 transcripts, unfilled box
indicating untranslated exon 10a present only in Spag16S. Arrows indicate primers
used to amplify specifically Spag16L or Spag16S message. (D) Specific primer sets
were used as indicated for PCR amplification of cDNA from adult mouse tissues: Testis
(T), Brain (B), Lungs (Lu), Oviduct (Ov), Heart (H).
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Figure 2-2. SPAG16isoforms have identical conserved domains. SPAG16S
appears before SPAG16L during the first wave of mouse spermatogenesis
(A) Alignment and conserved domain analysis of SPAG16L and SPAG16S proteins.
RNA (B) and protein (C) were isolated from mouse testis at the indicated day (bottom
row) after birth. (B) Specific primer sets were used to probe gene expression by PCR of
cDNA. (C) Protein samples were separated by SDS-PAGE and probed by Western
blotting with a C-terminal SPAG16 antibody that recognizes both SPAG16L (71 kDa
band) and SPAG16S (35 kDa band). Additional bands are not specific.
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Figure 2-3. SPAG16L is in the cytoplasm of male germ cells, SPAG16S is in both
the nucleus and the cytoplasm
(A) Cytoplasmic and nuclear fractions of adult mouse testis probed by Western blot for
SPAG16 (C-terminal antibody recognizing both isoforms) or markers of cytoplasm (αtubulin) or nucleus (Lamin B). (B) Sections of adult mouse testis immunolabeled with
SPAG16 C-terminal antibody or pre-immune serum (negative control). Arrows indicate
sample nuclear regions of heightened SPAG16 antibody immunoreactivity.
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Figure 2-4. SPAG16S shows enriched nuclear sub-localization
Mixed male germ cells from wild-type or transgenic SPAG16L-KO mice
immunolabeled with SPAG16 antibodies (red; N-terminal = SPAG16L only, Cterminal = both isoforms) and nuclear-stained with DAPI (blue). Pre-immune serum
for each antibody is included as a negative control.
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Figure 2-5. SPAG16S co-localizes with SC35 in nuclear speckles of mouse male
germ cells
(A) Mixed male germ cells immunolabeled for SC35 (green) or SPAG16 (red), with
DAPI as a nuclear marker. (B) Co-localization analysis of SC35 + SPAG16, n = 43.
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Figure 2-6. Transduction of SPAG16S induces SPAG16L expression in cultured
mouse male germ cells
Isolated adult mouse male germ cells were infected with an adenovirus causing
SPAG16S transduction or a control adenovirus. Following 48 hours in culture, RNA was
isolated and relative expression levels of indicated transcripts were measured. (* p<0.05
compared with Ad/Control)
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Figure 2-7. SPAG16S stimulates Spag16L mRNA and SPAG16L protein
expression in BEAS-2B cells
Analysis of Spag16L mRNA expression by real-time PCR in BEAS-2B cells stably
expressing SPAG16S (A) or transduced with Ad/SPAG16S (B). (C) Adenovirustransduced BEAS-2B cells immunolabeled with a C-terminal SPAG16 antibody. (D)
Analysis of SPAG16L protein expression by Western blotting in BEAS-2B cells infected
by Ad/SPAG16S. This panel demonstrates two independent experiments. (E) Relative
intensity of SPAG16L signal in panel D, normalized to Actin loading control for each
sample (relative Actin signal for Ad/Control = 47.5%, for Ad/SPAG16S = 52.5%) (*
p<0.05 compared with pTarget or Ad/Control)
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Figure 2-8. SPAG16S stimulates Spag16L promoter activity
Relative luciferase activity, normalized to PGL3 control promoter plasmid co-transfected
with pTarget control vector plasmid. Beas-2B cells were co-transfected with indicated
promoter/PGL3 constructs (Spag16L, Spag17, and Spag6) and either pTarget or a
SPAG16S/pTarget plasmid. Luciferase activity was measured after 48 hours to assess
promoter function. (* p<0.05 compared with pTarget control vector co-transfection;
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Figure 2-9. Identification of a Spag16L promoter region activated in the presence
of SPAG16S
Relative luciferase activity, normalized to PGL3 control promoter plasmid co-transfected
with pTarget control vector plasmid. Beas-2B cells were co-transfected with human
Spag16L promoter plasmids (corresponding to the indicated regions upstream of the
transcription start site) and either pTarget control or SPAG16S/pTarget. All promoter
constructs except the -100 bp promoter demonstrated significantly increased activity in
the presence of SPAG16S co-transfection. (* p<0.05 compared with pTarget cotransfection for a given promoter)
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Figure 2-10. Mouse and Rat Spag16S putative promoter and 5’-UTR regions
Sequences of mouse and rat transcription start sites and putative upstream
promoter regions. Putative transcription start sites as noted in red correspond
with GenBank sequences (mouse – NM_025728.3; rat – BC158602). Upstream
genomic regions are also as noted in GenBank (mouse – AY742710.2; rat –
NC_00508: 68851813 – 68853621). Alignment analysis performed using
MacVector v10.6.
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Chapter 3: Genetic Variation in SPAG16 Regions Encoding the WD40 Repeats is
not Associated with Reduced Sperm Motility and Axonemal Defects in a
Population of Infertile Males

Abstract
Background: SPAG16 is a critical structural component of motile cilia and flagella. In the
eukaryotic unicellular algae Chlamydomonas, loss of gene function causes flagellar
paralysis and prevents assembly of the “9 + 2” axoneme central pair. In mice, we have
previously shown that loss of Spag16 gene function causes male infertility and severe
sperm motility defects. We have also reported that a heterozygous mutation of the
human SPAG16 gene reduces stability of the sperm axonemal central apparatus.
Results: In the present study, we analyzed DNA samples from 60 infertile male
volunteers of Western European (Italian) origin, to search for novel SPAG16 gene
mutations, and to determine whether increased prevalence of SPAG16 single nucleotide
polymorphisms (SNPs) was associated with infertility phenotypes. Semen parameters
were evaluated by light microscopy and sperm morphology was comprehensively
analyzed by transmission electron microscopy (TEM). For gene analysis, sequences
were generated covering exons encoding the conserved WD40 repeat region of the
SPAG16 protein and the flanking splice junctions. No novel mutations were found, and
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the four SNPs in the assessed gene region were present at expected frequencies. The
minor alleles were not associated with any assessed sperm parameter in the sample
population.
Conclusions:

Analysis of the SPAG16 regions encoding the conserved WD repeats

revealed no evidence for association of mutations or genetic variation with sperm motility
and ultrastructural sperm characteristics in a cohort of Italian infertile males.

Introduction
Infertility impacts approximately 9% of couples globally, with reports ranging from 3.5% 16.7% of couples (de Kretser and Baker 1999), and it is estimated that male factor
infertility plays a role in as many as 55% of cases (Jurewicz, Hanke et al. 2009; Chemes
and Rawe 2010; de Kretser 2010). There are multiple causes of male infertility, including
congenital factors and environmental exposures (Zariwala, Knowles et al. 1993; Zariwala,
Knowles et al. 2007), as well as gene mutations which cause defects in spermatogenesis
and sperm flagellar dysfunction.

The most studied mutations associated with abnormal sperm motility and male infertility
cause the primary ciliary dyskinesias (PCD) (Ebersold, Levine et al. 1962; Pan, Wang et
al. 2005). Genes involved in the structure and function of the “9 + 2” axoneme, the
principle scaffold and regulator of motile cilia and flagella, have been extensively studied
and characterized in the biflagellate eukaryotic algae Chlamydomonas, wherein loss of
axonemal components has been shown to cause immotility (Bastin, Pullen et al. 2000;
Inaba 2003). Most of the mutations identified to date that cause PCD in humans encode
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proteins that are associated with the axoneme outer doublets. However, relatively little is
known about the contribution of mutations or genetic variation in genes encoding the
central apparatus of the axoneme to sperm motility defects. It is known that the “9 + 2”
axoneme is strongly conserved in overall structure and function (Sapiro, Kostetskii et al.
2002).

We previously reported that mice lacking Spag6, which encodes the mammalian
orthologue of the Chlamydomonas axonemal central apparatus protein PF16, exhibited a
phenotype of both male infertility associated with severe sperm motility defects and
axonemal structural abnormalities (Smith and Lefebvre 1997; Pennarun, Bridoux et al.
2002), demonstrating that loss of an axonemal central apparatus protein can have
dramatic effects in mammals as well.

SPAG16, the mammalian orthologue of the essential Chlamydomonas central apparatus
protein PF20 (Zhang, Kostetskii et al. 2006), is also required for male fertility and sperm
motility in mice (Zhang, Kostetskii et al. 2006). The Spag16 gene encodes two major
transcripts in mice, which generate SPAG16L, a central apparatus protein, and
SPAG16S, a protein localized to the male germ cell nucleus and cytoplasm. Male mice
homozygous for a mutation ablating SPAG16L production have a sperm motility defect
and are infertile (Lesich, Zhang et al. 2010). The axonemes of SPAG16L-deficient mice
also show abnormal responses to calcium, indicating that loss of SPAG16L disrupts
either the ability to process or the ability to respond to key molecular signaling (Zhang,
Kostetskii et al. 2004). When the transcripts encoding SPAG16L and SPAG16S are both
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disrupted in a transgenic male mouse, there is haploinsufficiency and abnormal
spermatogenesis in the chimeric state, implicating SPAG16S in fundamental processes
of sperm formation distinct from the structural role of SPAG16L (Zhang, Zariwala et al.
2007). Importantly, the Spag16 mutant allele affecting both isoforms was not transmitted
to offspring by chimeric males, demonstrating that heterozygous/non-homozygous
Spag16 mutation may cause a pronounced phenotype, and that the two murine SPAG16
isoforms each play different but essential roles.

We have also reported previously that sperm from human subjects heterozygous for a
frameshift mutation in SPAG16 exhibited instability of important central apparatus
components SPAG16L, SPAG17, and SPAG6 (Yatsenko, Arias et al. 2009). While both
subjects in this report were fertile, observed biochemical instability of the sperm axoneme
suggests that even heterozygous disruption of SPAG16 has phenotypic consequences
that may reduce fecundity. Additionally, a preliminary study of oligozoospermic and
oligoasthenozoospermic males has identified 29 previously unreported mutations in
SPAG16 transcripts isolated from ejaculated sperm, further suggesting a critical role for
SPAG16 in male fertility (Stirnimann, Petsalaki et al. 2010).

In the present study, 60 males of Western European (Italian) origin volunteered for
semen and genomic analyses following diagnosis of male factor infertility. We evaluated
the genomic region encoding the highly conserved WD domains of SPAG16 proteins
(exons 10-16). WD regions are semi-conserved 20 amino acid sequences giving rise to a
β-propeller tertiary structure. These domains are the only known functional domains
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found in SPAG16 proteins, both isoforms of which contain seven such domains. These βpropeller structures are classically thought to mediate protein-protein interactions
(reviewed in (Li and Roberts 2001)), playing crucial roles in macromolecular assembly
relevant to a diverse array of cellular tasks, including cell growth and division, intracellular
communication, apoptosis, and transcription regulation (Lau, Bachorik et al. 2009).
Recent reports have also demonstrated that some WD domains interact directly with
specific RNA sequences, further expanding the range of potential roles played by
members of this class of proteins (World Health Organization 1999).

To better understand potential links between SPAG16 gene variation and specific
mechanisms of infertility, semen analysis was performed for each subject (Baccetti,
Bernieri et al. 1995; Collodel and Moretti 2008). In addition, sperm ultrastructure was
assessed by transmission electron microscopy (TEM) and described according to
previously established standards (The International HapMap Consortium 2003).

Based on our previous observations of Spag16 gene function in mice, and the influence
of a heterozygous mutation affecting the WD repeat region in humans on central
apparatus stability, we hypothesized that functional SNPs in the human SPAG16 gene
could cause defects in sperm motility and ultrastructure manifest in both the
heterozygous and the homozygous states. The present study analyzed genetic variation
in a population of infertile males, and their association with parameters that are
potentially regulated by SPAG16.
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Results
SPAG16 sequences are highly conserved
In order to establish whether SPAG16 amino acid mutations were likely to result in
functional changes, amino acid sequences for several species were aligned to determine
regions of conservation within the protein. Alignments are shaded and boxed to indicate
identical amino acids relative to the human sequence or conservative substitution (Fig. 31). Quantitative assessment demonstrates greater similarity, as expected, between
mammalian SPAG16 sequences as compared to the Chlamydomonas sequence (Table
3-1). However, the region most conserved across all species is the C-terminal end, which
contains the WD40 repeat domains, the only known conserved domain within these
proteins.

While SPAG16 proteins are highly conserved, phylogenetic analysis demonstrates
especially strong relationships among mammalian forms, particularly rodents and
primates (Fig. 3-2). Only mice have two verified SPAG16 isoforms encoded by two
different transcripts: the flagellar form, found in all eukaryotic motile cilia and known in
mice as SPAG16L, and a testis-specific SPAG16S, which consists of the WD repeat
region. The only known rat SPAG16 is similar in structure to SPAG16S, and was isolated
from testis. Furthermore, the nucleotide sequence of the 5’-UTR of rat SPAG16 mRNA
[GenBank:NM_001134728.1] is similar to that found in mouse SPAG16S mRNA
[GenBank:NM_025728.3]. It is reasonable to speculate that a rat SPAG16L protein exists
containing both the conserved WD repeats on the C-terminal end and an approximately
equally sized N-terminus, consistent with the protein’s structure in all other species.
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Analyzed SPAG16 SNP allele frequencies are not altered in the sample population
For one SNP analyzed by Taqman Genotyping Assay, rs10167688, no individuals with
the minor allele were detected. This result was further corroborated by exon regionspecific sequencing. Heterozygosity for this SNP has been reported only in West African
Yoruban populations (The International HapMap Consortium 2003), so its absence in our
population was not unexpected. The probe set used to analyze this SNP was confirmed
to be effective using a test set of West African female DNA samples obtained in an
unrelated study (data not shown).

Two other SNPs were analyzed by TaqMan assay and confirmed by genomic
sequencing, which also demonstrated two additional SNPs present within splice
junctions. For all four of these SNPs, minor allele frequencies in our patient population
did not differ significantly (rs2042791: p = 0.86; rs2042792: p = 0.49; rs12623569: p =
0.87; rs16851495: p = 0.20) from those reported in previous genomic studies of a
reference population (Table 3-2) (Ng and Henikoff 2003). Each allele was found to be in
Hardy-Weinberg equilibrium. No other alternate alleles corresponding to SNPs identified
in previous genomic sequencing studies were found in the sample population. However,
the minor allele frequencies for all of putative SNPs not found in the present study
population are quite low or unconfirmed in the reference population (Table 3-3).

Of the four SNPs analyzed, two SNPs were found to be in linkage disequilibrium,
rs2042791 and rs2042792 (Table 3-4).
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Analyzed SPAG16 SNPs are not associated with alterations of axonemal or
periaxonemal ultrastructure, fertility index, and sperm parameters
In the infertile male population studied, semen analysis revealed severe defects in sperm
concentration, motility, and ultrastructure (full data in Table 3-5). No single parameter
was uniformly perturbed amongst all patients carrying a particular SNP minor allele.
Additionally, no mutation was found for which all homo- or heterozygous carriers
displayed a similar phenotype beyond deficiencies common to the sample (infertile)
population in general. There were nominally significant associations found between
specific SNPs and sperm ultrastructural characteristics, but these were not significant
after Bonferroni correction for multiple testing of 18 phenotypes with 7 genetic variations
(4 SNPs and 3 haplotypes), which resulted in a Bonferroni corrected p ≤ 0.000397 to
indicate significance at the 5% level. Minor allele carriage at rs16851495 correlated
negatively, but not significantly after Bonferroni correction for multiple testing, with normal
axoneme structures (β = -0.16, nominal p = 0.039) and with normal accessory fiber
structures (β = -0.12, nominal p = 0.041;). Minor allele carriage at rs12623569 showed a
small, nominally significant, positive correlation with normal fibrous sheath structures (β =
0.09, nominal p = 0.14) (Table 3-6).

For two SNPs [dbSNP: rs2042791; dbSNP rs2042792] in LD, haplotype was not
associated with studied sperm parameters or ultrastructural variation (Table 3-7).
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Amino acid-altering SPAG16 SNPs are predicted to be functionally tolerated
Two of the identified SNPs cause point mutations in SPAG16 proteins. These amino acid
substitutions were assessed for predicted effects on protein structure and function. Both
amino acid substitutions were predicted to be tolerated using SIFT (Schwede, Kopp et al.
2003), which analyzes amino acid properties and conserved identities.

The crystallographic structures of other WD repeat proteins have been determined and
these structures can be used to model the structure of the SPAG16 WD repeat region.
Using SWISS-MODEL (Sherry, Ward et al. 2001), SPAG16L was evaluated for homology
with proteins of known structure, and the amino acid sequence was aligned with that of
WDR5Delta23, a member of the WD repeat protein family. The locations of the amino
acid residues affected by the SNPs evaluated are labeled in the 3-D structure model
shown in Figure 3-3. K425 is predicted to be located on the periphery of the molecule,
which is not a known binding site of the structural homologue WDR5Delta23. Q361
extends into the predicted binding pocket.

Discussion
In the SPAG16 regions analyzed, both major and minor alleles were present in the study
group for four known polymorphisms, and no previously unreported mutations were
detected. At rs2042791 (The International HapMap Consortium 2003), the minor allele
replacement of an adenosine by a cytosine residue causes the replacement of a
glutamine at position 361 [GenBank: NP_078808.3] with a histidine. Previous genotyping
studies have reported a minor allele frequency of 0.39 (Ng and Henikoff 2003) in
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individuals of Caucasian ancestry for this SNP. Fisher’s exact test demonstrated no
significant difference between the measured minor allele frequency of 0.408 in our
sample population and that established in control populations (p > 0.05). While the
present study lacks sufficient power to detect small effects of these alleles on variation in
observed parameters of sperm characterization, among patients carrying this SNP no
single factor was uniformly deficient within the distribution of sub-normal semen analysis
of the study participants. Full genotype and semen analysis results are included for
reference (Supplemental Table 2).

The lack of association between this SNP and sperm dysfunction is not surprising, given
that the glutamine replacement by histidine is predicted to be tolerated in the protein
structure (The International HapMap Consortium 2003). Further, the amino acid is not
conserved in mammals – Mus musculus [GenBank:AAI20669.1, NP_080004.1,
NP_083436.2]

and

Rattus

norvegicus

[GenBank:NP_001128200.1,

AAI58603.1]

reference sequences for the orthologous proteins in fact report a histidine at this position,
consistent with the human minor allele. The same amino acid replacement is predicted in
Pan troglodytes [GenBank:XP_001148592.1, XP_526016.2, XP_001148393.1]. These
data are consistent with the hypothesis that structural rather than sequence homology is
essential to maintenance of axoneme function.

The rs2042792 minor allele was not found at a significantly different frequency than in the
reference population (p > 0.05), and did not correlate with assessed sperm phenotypes.
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Rs2042791 exists in LD with rs2042792 in our population, but no phenotypic
consequences were associated with any of the observed haplotypes.

Minor allele replacement of an adenosine with a cytosine in rs12623569 causes an
amino acid replacement at position 425 [GenBank:NP_078808.3], with a threonine taking
the place of a lysine. Previous genotyping studies have shown a minor allele frequency
for this SNP in individuals of Caucasian ancestry of 0.30 (Nagarkatti-Gude, Jaimez et al.
2011). The present sample population exhibited a minor allele frequency of 0.333, which
was not significantly different than that in control populations (p > 0.05). While the lysine
at position 425 encoded by the major allele is present in other mammals (Mus musculus
–

GenBank:NP_080004.1,

NP_083436.2;

Rattus

norvegicus

–

GenBank:NP_001128200.1, AAI58603.1), replacement by threonine is predicted to be
tolerated by the protein structure. Interestingly, minor allele carriage was found to be
nominally associated with a higher percentage of normal accessory fibers of the
axoneme.

Although the statistical significance of this association was lost upon

correction for multiple testing, further studies on a larger study population may be
warranted to identify contributions of the SNP to sperm flagellar structure.

At rs16851495, minor allele replacement of guanine with an adenine residue does not
affect protein translation directly, as the position lies outside the translated exon region.
However, minor allele carriage was nominally associated with the reduced presence of
normal axoneme structure in the study population. The statistical significance of this
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association did not withstand correction for multiple testing. However, the limited power
of our study may have contributed to the absence of a robust association.

For all SNPs discussed, both heterozygous and homozygous individuals were present in
the sample population, and statistical analysis demonstrated no difference in genotype
frequency between the sample and control populations (p > 0.05). While the study did not
have sufficient power to analyze possible contributions to complex traits, the results
negate the hypothesis that amino acid modification at the tested positions may result in a
loss of protein function that would mimic the severe phenotypes observed in transgenic
mouse studies.

Our results suggest that non-synonymous amino acid substitutions at residues 361 and
425 in the SPAG16 protein are not sufficient to explain a reduction of sperm motility and
fertility index, the presence of axonemal/periaxonemal alterations, or an increased
percentage of sperm pathologies in the assessed patient population. Based on the strong
homology between members of the WD protein family, it is tempting to suspect that these
resides may be non-essential in other WD repeat proteins as well.

The profound defects observed in studies of Spag16 gene effects in other species
suggest that a functional mutation would significantly perturb sperm function, and would
be observed even in a small sample population. Our observations do not, however,
preclude the possibility that alternative variations in the SPAG16 gene cause an increase
in sperm ultrastructural alterations, and a reduction in sperm motility. Indeed, our
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previous studies suggest that more significant SPAG16 mutations, such as a frameshift,
can reduce sperm central apparatus stability. Further studies of SPAG16 gene variation
are warranted to offer a comprehensive understanding of the gene’s contributions to
male fertility. The sensitivity of the present study to detect variation with the sample is
limited by the lack of similarly extensive sperm analysis data, in particular TEM
ultrastructural analysis, from a control population. Future development of this area of
research should include control samples from men with known fertility and/or sperm
count, motility, and structure in the normal range.

Future studies in mammals are necessary as well to explore the nature of Spag16 gene
evolution, and the possibility that male germ cell-specific isoforms exist in multiple
species. The only identified rat SPAG16 protein is similar to SPAG16S in size, and is
derived from mRNA similar to murine SPAG16S, with a 5’UTR from the region upstream
of the first exon suggestive of independent transcription, rather than splice variation. A
putative SPAG16S promoter and 5’UTR have been identified in humans as well
[GenBank: EF591776.1], raising the possibility that SPAG16S maybe be common to
mammalian male germ cells. We have recently shown that murine SPAG16S is enriched
within nuclear speckles of male germ cells (Sherry, Ward et al. 2001; The International
HapMap Consortium 2003). This unique localization, combined with phenotypic results
from various Spag16 transgenic mice, strongly suggests a unique processing role for the
SPAG16S protein, and thus a distinct role for the Spag16 gene apart from its structural
role in the axoneme.
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Conclusions
In a sample population of 60 infertile males of Western European origin, mutations in
SPAG16 were not significantly associated with a single phenotype of sperm alteration.
The findings suggest that mutations and or genetic variation in the SPAG16 regions
encoding the protein’s WD repeats are not likely to be major causes of sperm motility and
sperm flagellar defects.

Materials and Methods
DNA sample acquisition
DNA used in the present study was isolated from peripheral blood lymphocytes submitted
by 60 male volunteers of Western European (Italian) ancestry diagnosed clinically as
sub- or in- fertile. Inclusion criteria for patients were: sperm progressive motility
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normal lymphocyte karyotype, normal hormone levels, absence of anatomical
pathologies, genitourinary infections. Patients with known ultrastructural sperm defects of
possible genetic origin (dysplasia of the fibrous sheath, cilia immotile syndrome, round
headed sperm, etc.) were also excluded.

Ethics
Research was carried out in full compliance with the Helsinki Declaration of ethical
principles for medical research involving human subjects. All patients signed a
declaration of informed consent to participate in the research. The work was approved of
and performed in full accordance with policies governing human subject research at the
by the Ethics Committee for the University of Siena (CEL-AOUS) for specimens collected
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by non-invasive methods for clinical analysis, and the Virginia Commonwealth University
Institutional Review Board.

Genotyping
Allelic genotyping was performed using Applied Biosystems TaqMan SNP Genotyping
Assays according to manufacturer’s instructions. Specific allelic discrimination probes
and primer sets were ordered for the following 3 SNPs: dbSNP: rs2042791, rs12623569,
rs10167688. Results were compared to allele frequency detected in NCBI and HapMap
studies (Purcell, Neale et al. 2007).

Genotype was confirmed by direct sequencing. Briefly, exon plus flanking regions were
amplified by PCR and sequenced using tested primers. Primer suitability for sequencing
was tested by comparing results to sample PCR products digested and amplified in a
Topo TA Vector (Invitrogen).
PCR and Sequencing Primers
Ex10

–

Forward:

5'

-

TTCATGTAAATTCTGGGCAAA

-

3';

Reverse:

5'

-

-

3';

Reverse:

5'

-

GCAAACCATTTCAACCATGA - 3'
Ex11

–

Forward:

5'

-

TGGGGCCAGTACTCTCAAAA

TTCAGTGCAGGGTGTGTTGT - 3'
Ex12

–

Forward:

5'

-

GCAATTCAAGTTAGCAATTGTG

-

3';

Reverse:

5'

-

-

3';

Reverse:

5'

-

CCTGGGGTAGCATCAAGG - 3'
Ex13

–

Forward:

5'

-

TTATTTCATGCCTCAGTTCCTT

GCCCTTGCACAATCACTTTT - 3'
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Ex14

–

Forward:

5'

-

GGGAGGAGGGGCTAAAAATTA

-

3';

Reverse:

5'

-

CCTAAAGTTGTTCTTCTCACCTCA - 3'
Ex15 – Forward: 5' - AGAGGAATGTAATCTTATGGCTGT - 3'; Reverse: 5' TTCATATGACATGCTATACGTAATGA - 3'
Ex16

–

Forward:

5'

-

CTGACCCCTAACACAGAATGA

-

3';

Reverse:

5'

-

CCAGGTTTTCCTGCAGTTT - 3'

Statistical analysis
Fisher’s exact tests implemented in the open-source R software package were used to
test for differences between allele frequencies observed in the sample population and
those reported in HapMap for a population of Western European origin (Purcell, Neale et
al. 2007). Hardy-Weinberg equilibrium tests and inter-SNP linkage disequilibrium
calculations were performed using PLINK (World Health Organization 1999). Haplotypes
were assigned to subject based on the most likely phase reconstructed haplotype
generated by the expectation-maximization algorithm implemented in PLINK. Haplotypes
were then imported to R and an additive term for the haplotype of interested was coded
as 0, 1, or 2 based on copy number present. Single SNP and haplotype associations with
all phenotypes were carried out using multiple logistic regression in R. Phenotypes
measured as percentages were transformed with arcsine of the square root of the
percentage to stabilize the differences in variance between samples. The Fertility Index is
a standard measure ranging from 0 to 100+. All values greater than 100 were coded as
100. To achieve a more normal distribution and minimize residual errors, sperm/mL was
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analyzed using a log transformation. A Bonferroni p value was calculated to correct for
multiple testing error.

Sperm analysis
Semen samples of patients were collected by masturbation after 4 days of sexual
abstinence and examined after liquefaction for 30 min at 37°C. Volume, pH,
concentration (sperm x 106/mL) and total motility (a, rapid + b, slow, + in situ) were
evaluated according to World Health Organization guidelines (Baccetti, Bernieri et al.
1995; Collodel and Moretti 2008). For electron microscopy, sperm samples were
prepared as previously described (Baccetti, Bernieri et al. 1995).

In each sample the percentage of normal axonemal pattern, of coiled axonemes, of wellassembled fibrous sheaths and accessory fibers were estimated by TEM. Moreover, all
TEM data were elaborated using the statistical mathematical formula by Baccetti et al.
(Collodel and Moretti 2008), based on the Bayesian method, which calculates the
number of spermatozoa probably free of structural defects (fertility index, FI) and the
percentages of three main phenotypic sperm pathologies: immaturity, necrosis and
apoptosis (Schwede, Kopp et al. 2003).

Molecular structure prediction
Using SWISS-MODEL (Ng and Henikoff 2003), mouse SPAG16L was evaluated for
homology with proteins of known structure, and the results mapped on the 3-D structure
of the most closely related homologue.
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The molecular analysis tool SIFT (Thompson, Higgins et al. 1994) was used to predict
whether the analyzed amino acid substitutions would be tolerated, based on sequence
homology and amino acid physical properties.

Amino Acid Alignment
Alignment analysis, including scoring of conservative versus semi-conservative or radical
amino acid substitutions, was performed using recommended default settings in
MacVector 11.6 (MacVector. Inc.; Cary, NC) for the following isoforms:
Homo sapiens – GenBank:NP_078808.3
Mus musculus – GenBank:NP_083436.2
Bos taurus - GenBank:DAA32462.1
Gallus gallus - GenBank:XP_421865.2 (predicted)
Pan troglodytes - GenBank: XP_001148592.1 (predicted)
Chlamydomonas reinhardtii - GenBank:AAB41727.1
Micromonas sp. RCC299 - GenBank:ACO61299

Maximum Likelihood Tree
Amino acids sequences were aligned by ClustalW (CLUSTALW) using default settings,
hosted by GenomeNet at the Kyoto University Bioinformatics Center (Felsenstein 2005).
Aligned sequences were analyzed for maximum likelihood tree and formatted for figure
output using programs in the Phylip 3.69 software package (Li and Roberts 2001).
Isoforms used were as follows:
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C. reinhardtii – GenBank:AAB41727.1
M. pusilla CCMP1545 – GenBank:EEH57835.1
E. siliculosis – GenBank:CBN79843.1
P. patens – GenBank:EDQ58898.1
T. brucei – GenBank:AAC83819.1
T. gondii ME49 – GenBank:EEA99732.1
(Rooster) G. gallus – GenBank:XP_421865.3 (Predicted)
(Opossum) M. domestica - GenBank:XP_003341903.1 (Predicted)
(Macaque f.) M. fascicularis – GenBank:BAE01109.1
(Rhesus macaque) M. mulatta – GenBank:XP_001082826.2 (Predicted)
(Gibbon) N. leucogenys - GenBank:XP_003254083.1 (Predicted)
(Chimpanzee) P. troglodytes - GenBank:XP_001148592.1 (Predicted)
(Human) H. sapiens N-terminal variant – GenBank:NP_001020607.1
(Human) H. sapiens SPAG16L – GenBank:NP_078808.3
(Bull) B. taurus - GenBank:DAA32462.1
(Rat) R. norvegicus (discovered in testis; SPAG16S homologue) – GenBank:AAI58603.1
(Mouse) M. musculus SPAG16S – GenBank:NP_080004.1
(Mouse) M. musculus SPAG16L – GenBank:NP_083436.2
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Figure 3-1. Alignment of SPAG16 amino acid sequences
Aligned amino acid sequences are given for full-length proteins in human, mouse,
bull, rooster, chimpanzee, Chlamydomonas,
81 and Micromonas.

Table 3- 1. SPAG16 amino acid sequence conservation analysis
Quantitative assessment of identity scores (starting from left column) and similarity
scores (starting from top row), as calculated by MacVector alignment using default
settings.
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Figure 3-2. Sequence analysis of SPAG16 proteins
Maximum likelihood tree of SPAG16 and SPAG16-orthologous proteins (e.g. PF20).
The accession numbers for each entry are listed in the methods section.
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Table 3- 2. SPAG16 SNP distributions in sample population
Major and minor allele representation in the sample population. SNPs rs2042792
and rs16851495 are located in non-coding exon splice regions, while SNPs
rs2042791 and rs12623569 are in coding regions of SPAG16 mRNA, and alter
amino acid translation. The nucleic acid and amino acid positions indicated refer,
respectively,
to
mRNA
GenBank:NM_024532.3
and
to
protein
GenBank:NP_078808.3. Expected frequencies refer to the HapMap CEU
(European) study (The International HapMap Consortium 2003).
The sequenced region area also covered the following SNPs, for which no minor
alleles were found in the sample population: rs10167688, rs115473269,
rs61752199, rs2248214, rs28606463, rs114135655, rs113852644, rs117619722,
rs6746741, rs71855401, rs12988372, rs12988374, rs80016542. Location and
expected frequencies for SNPs not present in the sample population are given in
Table 3-3.
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Table 3- 3. Minor allele frequencies of all SNPs in the tested SPAG16 region
Expected minor allele frequencies refer to HapMap CEU European population (Baccetti,
Bernieri et al. 1995) where available. Unknown = no data available for suitable reference
population; * = Pilot 1 HapMap CEU panel, 60 individuals
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Table 3- 4. Analysis of Linkage Disequilibrium in Exon 11 SNPs
Linkage equilibrium analysis of two SNPs found in the sample
population and present in the genomic proximity: in order, rs2042791
and rs2042792. ‘2’ indicates minor allele, ‘1’ indicates major allele.
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Table 3- 5. Tests for association between all SNPs in sample population and sperm phenotype
Association tests for each SNP found in the sample population and studied indicators of sperm structure and function. * =
data assessed using arcsine of the square root of the phenotype; ^ = data assessed using log transformation of the
phenotype; c = Bonferroni correction results in p > 0.1
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Table 3- 6. Tests for association between haplotypes and sperm phenotype
Association tests for rs2042791-rs2042792 haplotypes and studied indicators of sperm structure and function. 2’ indicates
minor allele, ‘1’ indicates major allele. Transformations as in Supplemental Table 2, * = data assessed using arcsine
transformation; ^ = data assessed using log transformation.
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Table 3- 7. Genotype and phenotype analysis of each study participant
Semen parameters and TEM sperm analysis results for each patient. For SNPs, 0-2 indicate number of minor alleles at
the given location, hence 0 = homozygous major allele, 1 = heterozygous, 2 = homozygous minor allele. Ax norm =
Normal axoneme structure 9+2 by TEM examination; Ax coiled = Coiled axoneme by TEM examination; Accfibers norm =
Normal accessory fibers structure by TEM examination; Fibrous sheath norm = normal fibrous sheath structure by TEM
examination; FI = Fertility Index; Imm = % Immaturity (normal < 55%); Apopt = % Apoptosis (normal < 5%); Necr = %
Necrosis (normal <21%). FI and sperm pathologies (immaturity, apoptosis, necrosis) were assessed by TEM . VaLf = Left
varicocele; CripRg = Right Cryptorchidism; ExVaLf = Operated Left Varicocele; VaRg = Right Varicocele; VaBil = Bilateral
Varicocele
ID

rs204 rs204 rs126 rs168
2791 2792 23569 51495

Ax
Acc Fibrous Spm/ Vol
Ax
Motility in
nor
fibers Sheath mL
/
coiled
a+b
situ
(9+2)
nor
nor
10 6 mL

FI

Imm

Apopt

Necr

Path

Semen
Hormo
Infecti
nes
ons
Strp.
Anginosu
s

101

1

1

0

0

11/24

7/28

12/20

1/18

0.975

4

3+5

5

60

52.86

15.7

67.9

ExVaLf

102

2

2

0

0

0/23

19/23

1/23

0/21

74

2.5

0+1

1

0

94.61

21.9

98.7

ExVaLf

103

2

2

0

1

0/18

16/30

3/22

3/27

0.48

3

0

0

0

65.75

12.5

98.4

104

1

1

1

0

6/31

9/26

6/22

6/24

4.88

5.5

3+5

10

193

86.58

4.1

61.3

105

1

1

0

0

8/13

2/13

4/8

2/11
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Figure 3-3. Predicted approximate 3-D structure of SPAG16
Predicted 3-D structure of human SPAG16L as determined by overlay on the known
structure of WDR5Delta23, the closest related protein with a known crystal structure.
Location of SNP-affected amino acids is indicated by shaded sections.
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Chapter 4: Perspectives

Throughout the course of this dissertation, I have presented data that describe the roles
of Spag16, a bifunctional gene playing a highly conserved role in eukaryotic motile cilia
as well as an important role in mammalian male germ cell development. The involvement
of Spag16 in spermatogenesis has been suggested by previous work, predominantly
published by our lab, and is a particular focus of the work presented here.

In Chapter 1, I presented background information for the dissertation, beginning with the
twin clinical goals that have prompted these studies: understanding male infertility, and
developing male contraceptives. Previous studies by our lab have strongly suggested a
novel role for the mammalian Spag16 gene aside from its conserved structural role,
leading to the central hypothesis of this work that Spag16 has evolved an additional
function unique to mammalian male germ cells. This prior work from our lab has shown
that mice have two distinct isoforms of SPAG16: a longer SPAG16L that fulfills the
conserved structural role in all eukaryotic motile cilia, and a shorter SPAG16S, found only
in male germ cells and present in the nucleus as well as the cytoplasm. While transgenic
mice lacking SPAG16L are infertile and show defects in sperm motility, mice with both
SPAG16S and SPAG16L disrupted fail to transmit the mutant allele, and exhibit a
phenotype of spermatogenesis arrest at the round spermatid stage, leading us to
hypothesize that nuclear SPAG16S plays an important role in sperm maturation.
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In Chapter 2, I presented new information on the localization of murine SPAG16S,
demonstrating that the protein concentrates in sub-nuclear structures known as nuclear
speckles. The appearance of these SPAG16S-enriched nuclear speckles is concurrent
with haploid sperm maturation at the round spermatid stage, the point of
spermatogenesis at which sperm development was disrupted in a highly chimeric
transgenic mouse with SPAG16S (as well as SPAG16L) disrupted. I also demonstrated
that SPAG16S is capable of eliciting SPAG16L expression and of binding to the Spag16L
promoter. While these data do not explain the phenotype seen with disruption of
SPAG16S, they provide the first evidence of a specific SPAG16S function, consistent
with the gene regulatory role suggested by SPAG16S localization in nuclear speckles.

In Chapter 3, I examined a patient population of 60 infertile males with low sperm motility
to see if SPAG16 gene mutations might be a contributory factor to their infertility. I
designed primers to fully sequence exonic regions of SPAG16 corresponding to the
shared SPAG16L and SPAG16S functional domains. No novel mutations were found,
and previously reported SNPs were found at a frequency not significantly different from
that found in a control population, Europeans enrolled in the International HapMap study.
Extensive EM and semen analyses were performed by our collaborators, and we tested
these sperm parameters for association with SNPs and haplotypes in our patient
population. After correction for multiple testing, no significant associations were found.
These data suggest that identified SPAG16 polymorphisms are not functionally
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detrimental to either SPAG16L or SPAG16S, as we have seen that loss of these proteins
carries significant phenotypic consequences in mice.

Related Projects
This section will discuss related work to evaluate the full implications of the presented
data, suggest insights into functional mechanisms, and outline directions of future study.
Given that the only identified functional domains of both SPAG16S and SPAG16L are
WD repeats, which are known to mediate protein-protein interactions, it is highly likely
that both proteins function via interaction partners. Three yeast two-hybrid screens have
been performed (two within the context of this dissertation, one previously) using the
mouse SPAG16S/C-terminal SPAG16L sequence as bait against libraries of normalized
mouse and mouse testis cDNA (Clontech).

The results of the these interaction studies have varied, perhaps suggesting that
SPAG16 proteins are promiscuous but unenthusiastic interactors outside the presence of
defined macromolecular structure components, such as the conditions found surrounding
SPAG16L in the axoneme central apparatus. Despite ongoing efforts, thus far it has not
been possible to reliably predict WD interactors based on analysis of any putative
epitope-like specific sequences within WD repeats (Zhang, Kostetskii et al. 2004). The
putative interactors presented below suggest possible SPAG16 functions by association.
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Meig1
Our lab published the first studies suggesting an interaction between SPAG16 and
MEIG1 (Don, Winer et al. 1994; Ever, Steiner et al. 1999), a 15-kDa protein expressed
abundantly in murine testes during and immediately after meiosis (Zhang, Kostetskii et al.
2004). Based on yeast two-hybrid screens and supported by co-immunoprecipitation, an
important interaction was hypothesized between the WD region of SPAG16 and Meig1
(Steiner, Ever et al. 1999).

Initial results in the literature theorized that MEIG1 played an important role in the early
stage of meiosis, when it was observed in the nucleus interacting with spermatocyte
chromosomes (Zhang, Shen et al. 2009). The nuclear localization of MEIG1 suggested
an interaction with SPAG16S, rather than SPAG16L, yet the spermatogenesis arrest in
the chimeric SPAG16 mouse at the round spermatid stage led to a hypothesis that the
crucial role for SPAG16S occurred post-meiotically.

In order to better understand the germ cell-specific roles of the MEIG1 protein, and shed
light on the importance of SPAG16S interaction, a conditional Meig1 knockout mouse
was

generated

(Clermont,

Oko

et

al.

1990;

Zhang,

Shen

et

al.

2009)(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746124/). Homozygous Meig1-null
mice were found to be viable, but completely sterile, with very few, morphologically
abnormal sperm. There were no other observed defects that would suggest ciliary
immotility. Importantly, spermatogenesis in Meig1-null males progressed normally
through meiosis, refuting the hypothesis that MEIG1 plays a critical role at this juncture.
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However, the final stages in sperm development, those of elongation and condensation,
failed to progress. A failure of spermiogenesis after the round spermatid stage strongly
resembles the phenotype of the Spag16 chimeric mouse ascribed to lack of SPAG16S,
and provides interesting anecdotal support for the hypothesis that MEIG1 and SPAG16S
interact at the round spermatid stage to regulate the final stages of sperm development.

Spermiogenesis disruption in Meig1-null males was linked to a specific ultrastructural
defect, failure of manchette formation. The manchette is a transient microtubular
structure that assembles during spermatid elongation, and is believed to play a role in
transport of proteins within the developing sperm tail (Salzberg, Eldar et al. 2010). In
sperm from Meig1-null males, components of this structure, such as actin and tubulin,
were observed to be present in the cytoplasm, yet disorganized.

A similar, independent study noted the same phenotype of sterility and lack of sperm
development in the elongation and condensation stage. Scanning EM revealed the
presence of gross sperm head malformations and misconnections to the tail, yet did not
address sub-cellular structures such as the misformed manchette components we
reported (Zhang, Kostetskii et al. 2004).

Both of the above-referenced studies were conducted in animals with a global
inactivation of Meig1. In order to establish the timing of MEIG1 activity and to confirm the
germ cell specificity of the phenotype, the conditional knockout mouse was crossed with
mice expressing Cre recombinase under the control of several specific testis-related
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promoters: Hsp2a (heat shock protein 2; spermatocytes), Prm (Protamine 1; post-meiotic
spermatids), and Amh (anti-Mullerian hormone; Sertoli cells) (Appendix 1).

Germ cell-specific disruption of Meig1 at the spermatocyte stage, in the presence of
Hsp2a-Cre, resulted in a phenotype with no observable difference from that seen with
global Meig1 disruption under the control of Cmv-Cre: male mice were infertile and
exhibited failure of spermiogenesis. Male mice with a later germ cell-specific disruption of
Meig1, under the control of Prm-Cre, exhibited dramatic reductions in Meig1 mRNA and
MEIG1 protein, yet were completely fertile and displayed normal sperm count and sperm
motility. Sertoli cell-specific disruption of Meig1 due to the action of Amh-Cre had no
effect on sperm function, testis histology, or fertility.

These data further highlight the existence of a critical point in sperm development near
the end of meiosis as elongation and condensation are initiated, and suggest that Meig1
plays a role at this same juncture disrupted when SPAG16S is not present. While a role
for SPAG16S-MEIG1 interaction in manchette assembly at the round spermatid stage
cannot be firmly established, we hypothesize this highly plausible mechanism on the
basis of these collected data. We speculate that the Spag16 gene has evolved to
regulate its own expression, with nuclear SPAG16S coordinating the assembly and
trafficking of cytoskeletal components with which cytoplasmic SPAG16L will interact in
the axoneme. This hypothesis is consistent with the observation the SPAG16S regulates
SPAG16L expression (Chapter 2), and is consistent with the relatively moderate,
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“downstream” phenotype observed in mice lacking SPAG16L compared to the
spermiogenesis arrest seen with concurrent disruption of SPAG16S.

RC/BTB2
The same study that identified MEIG1 as a SPAG16 binding partner (Tang, Lalli et al.
1982; Berruti and Paiardi 2011) also elicited RC/BTB2 as a candidate SPAG16 interactor
following a yeast two-hybrid screen. Like Spag16, murine Rc/btb encodes both a somatic
isoform and a testis-specific isoform. The testis-specific transcript, Rc-btb2, appears in
male mice at day 8 after birth but reaches high levels of expression at day 20 (Wang,
Teves et al. 2012)(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387240/), concurrent
with the first wave of spermatogenesis and slightly preceding expression of Spag16S at
day 20 (Chapter 2). The RC-BTB2 protein is not heavily expressed in testis until day 30,
at which point the first cohort of round and elongated spermatids has been produced.

A full-length GFP-tagged RC/BTB2 construct and a GFP-tagged BTB domain alone were
present asymmetrically along the nuclear membrane of transfected CHO cells. In mouse
testis sections, RC-BTB2 was observed in round spermatids, where it co-localized
significantly with a marker for the acrosome, peanut lectin. The acrosome is a highly
conserved structure in male germ cells present across one side of the nucleus at the
beginning of spermiogenesis. This organelle is believed to derive from the Golgi and
function as a spermiogenesis-specific secretory vesicle (Yu, Ng et al. 2008). While
SPAG16 interaction data remain limited to the yeast two-hybrid screen, the timing of RCBTB2 condensation and its specific nuclear location are consistent with the observation
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that SPAG16S-related proteins localize discretely at the beginning of spermiogenesis,
and seem to play crucial roles in trafficking and assembly of spermiogenesis-specific
cellular components.

SOX5
Given the strong evolutionary conservation of axoneme genes, many of them are subject
to common regulatory mechanisms. One transcription factor gene, Foxj1, has been
established as a master regulator of ciliogenesis (Okada, Ohta et al. 2004). Loss of this
gene has been shown to fully disrupt motile cilia formation in a variety of tissues,
including mammalian oviduct (Brody, Hackett et al. 1997), airway (Blatt, Yan et al. 1999),
and embryo (Hiraoka, Ogawa et al. 1998).

The evolution of novel isoforms (e.g. SPAG16S) from conserved axoneme genes in
mammals supports the notion that new regulatory mechanisms must also exist to control
the more complex array of genes activated in mammalian ciliogenesis. We examined
Sox5, a transcription factor gene that expresses both a somatic isoform in mice and an
isoform first discovered in testis, known as S-SOX5 (Zhang, Sapiro et al. 2002).

Spag6, a known central apparatus gene and an important interaction partner of
SPAG16L (Kiselak, Shen et al. 2010), contains several predicted SOX5 binding sites in
its

promoter

region

(Kiselak,

Shen

et

al.

2010;

O'Toole,

Giddings

et

al.

2012)(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945543). The S-SOX5 transcript
and protein are present in murine testis, lungs, and brain – all tissues with motile cilia.
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We demonstrated that SOX5 was able to elicit Spag6 promoter function both
independently and synergistically with FOXJ1 in model epithelial cell lines (BEAS-2B =
respiratory; MDCK = kidney). While data from this work focuses on the Spag6 promoter,
Spag16L and Spag17 promoters are also responsive to SOX5, suggesting that S-SOX5
may play a general role in cilia formation in mammals. Interestingly, the putative
Spag16S promoter region was not responsive to S-SOX5 (data not shown), which may
indicate a temporally different activation and/or an inability to function in ciliated cell types
other than male germ cells. Similar to the work discussed here on SPAG16, we
hypothesize that elucidating the roles of the S-SOX5 protein may help clarify the unique
aspects of mammalian ciliogenesis.

Future Directions
Spermatogenesis has been extensively studied in both mice and humans, and to a
somewhat lesser extent in rats. Critical genes have been suggested by Chlamydomonas
work on the axoneme, and the mammalian functions of these genes explored largely
through the use of transgenic mouse models. Yet a lack of comprehensive gene
expression studies across species limits the insights of comparative biology with respect
to spermatogenesis.

Recent work in the field has utilized advanced imaging techniques to compare human
and Chlamydomonas cilia, and thus highlight the fact that important differences exist in
both the structure and composition of these related structures; Chlamydomonas and
Homo sapiens are separated evolutionarily by over a billion years, and there have been
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design tweaks along the way (Hoops and Witman 1983). Prior studies have pointed out
Chlamydomonas structures lacking in human cilia, such as certain bridges between outer
doublets and projections from the outer doublets (Wanner, Salathe et al. 1996; Silflow
and Lefebvre 2001). Additionally, it is known that Chlamydomonas flagella can express
two waveforms in their flagella, while human cilia are capable of only one waveform
(Silflow and Lefebvre 2001).

Our work is particularly interested in the evolution of the central pair, the axoneme region
where SPAG16L enables assembly and coordination of the core structure of the
cytoskeleton. Interestingly, it has been observed that the central pair rotates in
Chlamydomonas, causing a gradual twist within the flagellum, whereas the central pair is
rotationally static in humans (O'Toole, Giddings et al. 2012). Instead, connections
between the central pair (specifically C2) and the outer spokes are enhanced in humans
(Lechtreck, Delmotte et al. 2008). This same phenomenon has been observed in mice
(The International HapMap Consortium 2003), which supports the hypothesis that
mammalian axonemes express important differences from Chlamydomonas standards as
a result of shared evolutionary history. Speculatively, we hypothesize that the presence
of SPAG16 in the center of the axoneme may have conferred built-in evolutionary
flexibility, as WD protein promiscuity may allow for the introduction and interaction of new
polypeptides.

In Chapter 3 I discussed the conservation of Spag16 in eukaryotes, yet analysis of
isoform evolution is somewhat speculative in light of current predictive, rather than
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established, data from other mammalian species. We speculate that the evolution of
SPAG16S and its testis-specific interaction partners may reflect a branch in
spermatogenic strategies; however, at present it is not possible to conclusively state
which species express this isoform and which do not, and thus we remain insufficiently
informed to describe the molecular bases of differing spermatogenesis mechanisms.

When both SPAG16 isoforms are disrupted, but not when SPAG16L alone is disrupted,
murine

spermatogenesis

is

arrested

at

the

junction

between

meiosis

and

spermiogenesis. When the SPAG16S interaction partner MEIG1 is not present in mouse
male germ cells at the late stages of meiosis, males are infertile, and an important
structure responsible for intracellular trafficking during spermiogenesis fails to assemble.
RC/BTB2, another potential interaction partner of SPAG16S, assembles at the sperm
nuclear head during the same stage of sperm development that appears to require both
SPAG16S and MEIG1. Just prior to condensation and elongation, as haploid round
spermatids begin the last stage of specialized development, SPAG16S becomes highly
concentrated in transient sub-nuclear structures known as speckles, splicing factorenriched structures which are only somewhat understood in somatic cells and virtually
unexplored in male germ cells.

I have presented new information on a gene that plays two highly distinct roles in male
fertility, yet I have also demonstrated that the two isoforms of this gene are related in
their expression and actions. Evidence from studies of Spag16 interaction partners
suggests that the germ cell-specific SPAG16S may play a role in the nucleus to enable
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formation of the specialized structures in developing sperm that guide cytoplasmic
SPAG16L to its established location with the central apparatus of the “9 + 2” axoneme.
Future studies to define expression of non-canonical SPAG16 isoforms and further
elucidate mechanisms by which haploid male germ cells coordinate nuclear
condensation and elongation will continue to clarify the numerous roles of the Spag16
gene.
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